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T-cells use the endocytic pathway for key cell biological functions, including receptor 
turn-over and maintenance of the immunological synapse. Some of the established 
players include the Rab GTPases, SNARE complex proteins, and others which in non-T-
cell systems function together with Eps15 Homology Domain-containing (EHD) proteins. 
To date, the role of the EHD protein family in T-cell function remains unexplored. We 
generated conditional EHD1/3/4 knockout mice using CD4-Cre and crossed these with 
mice bearing a myelin oligodendrocyte glycoprotein (MOG)-specific TCR transgene. We 
found that CD4+ T-cells from these mice exhibited a reduced antigen-driven cell 
proliferation and IL-2 secretion in vitro. In vivo, these mice exhibited reduced severity of 
experimental autoimmune encephalomyelitis. Further analyses showed that recycling of 
the TCR-CD3 complex was impaired, leading to increased lysosomal targeting and 
reduced surface levels on CD4+ T-cells of EHD1/3/4 knockout mice. Our studies reveal a 







































I first want to thank you God for always being there for me. Thank you for everything! 
I want to acknowledge you, my advisor Dr. Hamid Band, for giving me a chance to join 
your lab and be trained by you. You have been a very supportive mentor to me and I will always 
be thankful for that. When I joined the lab, I had little experience in doing experiments and 
writing scientific literature. You started first by recommending articles to read, then, giving 
details on how I should run some experiments, explaining to us how to give presentations, editing 
our drafts for different application and you just went on. You have led by example in showing me 
how a scientist should think, critique and also take constructive criticisms. You always 
encouraged me to pursue my academic goals and were always available anytime I had a question 
or just needed to talk. You have been there in my ups and downs. You have seen me get engaged, 
get married, have my first son and now, pregnant with my second child. You never judged me or 
treated me differently than anyone in the lab. You have helped shape my life to where I am now 
and I will forever be grateful for that.  With all my heart, thank you. 
To all my supervisory committee members, I will forever be grateful for all the help, 
support, advice, mentorship, and attention you all have provided for me.  
Dr. Joshi, you have not only helped answer my many questions, but you have provided 
equipment for me to use, asked your lab members to help me with some protocols, and have been 
very supportive. You are always available to talk and always willing to help. I really thank you 
for that.  
Dr. Lee Mosley, although you are one of the newest members in my supervisory 
committee, I always felt like you were part of my training from the start. You have provided 
tremendous help in my 2D2 model system. You have suggested experiments to do, helped figure 
v 
 
out some protocols, asked one of your student to train me on how do the whole mouse perfusion 
fixation to get good fixation of the brain, you have provided equipment for to use, you have 
helped me with some statistics, and more. I will forever be grateful for all you have done for me. 
Thank you.  
Dr. Gargi, although you are new to our department and as my supervisory committee 
member, you are very open and easy to talk to. You have made yourself available to help me for 
my search for a post-doctorate position, you have provided equipment for me to use and have 
been very supportive of my work. I really appreciate you and I am thankful for all you have done 
for me. Thank you. 
Dr. Joyce, I personally feel like you have been another mentor to me. You have not only 
provided professional help, but also personal help to me. I have come to you with frustrations, 
worries, questions, doubts, and all kinds of situations and you always made time to talk to me. I 
really appreciate all you have done for me. You have pointed me to the right directions, and have 
been there for me whenever I needed you. You have provided me with protocols, still helping me 
find a post-doctoral position, and encouraged and pushed me to fulfill my goals. Even when I 
needed some teaching experience, you not only provided the opportunity for me to do so, but you 
trusted me enough to lecture two of your classes two years in a row! Words cannot express my 
gratitude to you. I will forever be grateful for all you have done for me. Thank you. 
Dr. Karen, although you are not part of my supervisory committee, I still want to thank 
you for all you have done for me. You were the first person here at UNMC to believe in me. 
Right from the day of my interview, you believed that I was going to do great in all my classes 
and that I was going to finish my PhD. Now, here I am, just about a month before my graduation; 
all I can say is thank you. You have been available to talk with me about anything I needed to talk 
vi 
 
about. You have been very supportive and really, worthy of your title. Thank you for all you have 
done for me. 
Family and friends 
 
To all my siblings, cousins, uncles, and aunts and close friends, I say thank you for everything.  
To the Ross family, I want to say thank you from the bottom of my heart. You all have 
provided so much support to my family and me. You were already like a family to me. Your 
home has become a second home for my son, and you guys have really been there more than 
some family members could have been for us. You made it possible for me to do late 
experiments, go back to the lab after 6pm for any reason I had while you watched Dinovic for me. 
You have provided spiritual, moral, personal, financial, and material support to me and my 
family. Thank you for being part of my journey. You have made it possible for me to finish my 
Ph.D. program and I will forever be grateful.  
To my grandmother, Nsikala Mpenge, I say thank you. You came and helped me with our 
son when I needed help the most. You spent 2 months of your time taking care of Dinovic so I 
could have all the time I needed in the lab and writing my thesis. You always call to check on us 
and are always willing to help. Thank you grandma! 
To my aunt, Therese Nseka, I say thank you. When I had Dinovic, you came and took 
care of him and me. You cooked, cleaned, and did everything so that I would not worry about 
anything. Thank you for all you have done for us.  
To my parents, I say thank you. You have been a tremendous help to us. You have 
provided all kinds of support for us including financial, moral, spiritual, material, etc. You have 
always been my number one support in everything I have ever done in life. You always believed 
vii 
 
in me and your love for me is inexpressible. Thank you for being the best parents I can ever ask 
for. Words cannot express my gratitude to you. I love and thank you both from the bottom of my 
heart. 
To my immediate family, my husband, my son and new coming baby, I say thank you. 
To my husband, you have been more than what I could ask for. You are a very supportive, caring, 
unselfish, and loving man I have ever known. You have been my best friend, the best husband 
and the best father for our son. You started taking care of Dinovic since he was only 7 weeks and 
you still do. I cannot even count the number of times you had to leave work to come home and 
take care of him just so I can get ready for a presentation, or fellowship application, or whatever I 
needed help with. You are just awesome! And Dinovic, you have been the best gift from God to 
us. You have always been a healthy baby, very kind, very smart and just amazing. Thank you for 
understanding and being patient with me for all the times someone else had to watch and care for 
you while I was at school or studying. You both have been the best! I love you both so much and 
with all my heart I say thank you for making it possible for me to be able to finish my degree. I 










TABLE OF COTENTS 
 
Title Page                                                                                                                                           i 
Abstract                                                                                                                                             ii 
Dedication                                                                                                                                        iii 
Acknowledgements                                                                                                                          iv 
Table of Contents                                                                                                                           viii 
List of Figures                                                                                                                                   x 
List of Tables                                                                                                                                   xi 
Lists of Abbreviations                                                                                                                     xii 
Chapter 1: Introduction                                                                                                                     1 
1. Endocytic Trafficking                                                                                                          2 
1.1 Overview                                                                                                                       2 
1.2 Routes of Endocytosis                                                                                                   6 
1.3 Endocytic Trafficking Endosomes                                                                              11     
2. Regulators of the Endocytic Trafficking                                                                            14 
2.1 Rab GTPases                                                                                                               14 
2.2 EH-Domain Containing Protein Family                                                                      16 
3. EHD Protein Family                                                                                                          19 
3.1 EHD Protein Structure                                                                                                 19 
3.2 Function of EHD Proteins in Vitro and in Vivo                                                          24 
4. T cell Functions                                                                                                                  30 
4.1 Overview of T cell Development                                                                                30 
4.2 T cell Activation and Immunological Synapse (IS)                                                    31 
4.3 Endocytic Trafficking in T-cells                                                                                 33 
4.4 Similarities between IS and other Synapses                                                                36 
4.5 Potential Role of EHD Protein Family in T cell Function and in the IS                     37 
Chapter 2: Materials and Methods                                                                                                  39 
5. Materials and Methods for Chapter II                                                                                40 
5.1  Reagents & Antibodies                                                                                               40 
5.2  Mice Generation & Genotyping                                                                                 41 
5.3  Table: Primers Used for tail PCR Genotyping                                                           42 
5.4  Western Blotting                                                                                                         43 
5.5  CD4+T-cell Isolation                                                                                                  43 
5.6  Fluorescence Activated Cell Sorting (FACS)                                                            43 
ix 
 
5.7  CFSE and Cell Trace Violet-Cell Proliferation Dye Dilution Assay                         44 
5.8 3H-Thymidine Incorporation Assay and T-cell Expansion                                        44 
 
5.9 In-vitro Deletion of EHD Proteins (EHD1, 3 and 4)                                                 45 
5.10 ELISA                                                                                                                        45 
5.11 Cell Surface TCR Internalization Assay                                                                    45 
5.12 Analysis of TCR Recycling                                                                                       46 
5.13 Confocal Microscopy                                                                                                 47 
5.14 Induction and Monitoring of Experimental Autoimmune Encephalomyelitis          47   
5.15 Statistics                                                                                                                     48                                                                                             
Chapter 3: Requirement of EHD protein family for T cell function                                               49 
6. Introductions                                                                                                                      50 
7. Results                                                                                                                                53 
7.1  Multiple EHD family members are expressed in lymphoid organs and purified CD4+                                                
T-cells.                                                                                                                         53 
7.2  CD4-Cre mediated conditional deletion of EHD1/3/4 in T-cells leads to a reduced 
proportion of CD4+ T-cells in secondary lymphoid tissues.                                       55                                                                                                    
7.3  Expression of EHD proteins is required for optimal antigen-induced T-cell activation 
in vitro and for EAE in vivo.                                                                                       56 
7.4  EHD proteins regulate the traffic of the TCR-CD3 complex to the cell surface.      58 
7.5  Deletion of EHD1, 3 and 4 promotes the lysosomal degradation of TCR-CD3.       60 
8. Discussions                                                                                                                        61 
9. Figures                                                                                                                                65 
Chapter 4: Summary and Future Directions                                                                                 102 
10. Significance and innovation                                                                                             103   
11. Conclusions                                                                                                                      111 
12. Future Directions                                                                                                             112                                                          
Chapter 5: Bibliography                                                                                                                114 










LIST OF FIGURES 
 
Chapter 1 
Figure 1.1:  Pathways of Endocytosis. 
Figure 1.2: Architecture of EH domain-Containing Proteins. 
Figure 1.3:  Structures of EHD Proteins. 
Figure 1.4:  Structure of Activated EHD4 Dimers. 
Figure 1.5:  Endocytic Trafficking of Signaling Receptors. 
Figure 1.6:  Later Stages of the IS in T-cells: Vesicles Trafficking and Changes in Polarization 




Figure 1: Expression of EHDs in Lymphoid Tissues and Isolated CD4+ T-cells. 
Figure 2: EHD Proteins Show Differential Expression during T-cell Stimulation. 
Figure 3: Potential Redundant Functions of EHD Protein Family. 
Figure 4: Generation of the TgTCR; CD4-Cre; EHD (1, 3, 4) flox/flox. 
Figure 5: The CD4 Transgenic TCR Mice (2D2) Express Normal Levels of EHD Proteins and 
Respond to MOG Peptide, but not the OVA Control Peptide. 
Figure 6: CD4-Cre Mediated Conditional Deletion of EHD 1, 3 and 4 does not Impact Thymic T-
cell Development but Leads to a Relative Decrease in CD4+ T-cells in Secondary Lymphoid 
Tissues. 
Figure 7: Conditional Deletion of EHD 1, 3 and 4 in T-cells Leads to Reduced Cell Proliferation 
and IL-2 Secretion. 
Figure 8: Conditional Deletion of EHD 1, 3 and 4 leads to Impairment of Basal Recycling of 
TCR-CD3 from Endocytic Compartments to The Cell Surface. 
Figure 9: Conditional Deletion of EHD 1, 3 and 4 leads to a Reduced Level of the CD3Ɛ 
Component of TCR-CD3. 
xi 
 
Figure 10: Conditional Deletion of EHD 1, 3 and 4 leads to Lysosomal Degradation of TCR-
CD3. 





















LIST OF ABBREVIATIONS 
                    
APCs                                           Antigen Presenting Cells  
Arf ADP-Ribosylation Factor 
ATP    Adenosine-5’-Triphosphate 
ATPase                ATP Hydrolysis Enzyme 
BSA    Bovine Serum Albumin 
CALM                                         Clathrin Assembly Lymphoid Myeloid Leukemia 
CavME                                        Caveolae-Mediated Endocytosis 
Cav1                                           Caveolin-1 
CIE                                              Clathrin-Independent Mediated Endocytosis 
CCP                                             Clathrin-Coated Pits  
CCV                                            Clathrin-Coated Vesicle  
CDH23                                       Cadherin -23  
CME                                           Clathrin Mediated Endocytosis  
C-terminal At the Carboxyl-Terminus  
CTL                                            Cytotoxic T Lymphocytes 
CTLA-4                                      Cytotoxic T Lymphocyte-Associated Protein 4 
cSMAC                                       Central Supra-Molecular Activation Complex  
DMSO                Dimethyl Sulfoxide 
DN                                              Double Negative 
DP                                               Double Positive  
EAE                                            Experimental Autoimmune Encephalomyelitis 
EE                                               Early Endosomes  
xiii 
 
EEA1    Early Endosomal Antigen-1 
EGFR                                          Epidermal Growth Factor Receptor 
EHBP1                EH Domain Binding Protein 1 
EHD                                            EPS-15 Homology Domain-Containing Protein 
Eps15    Epidermal Growth Factor Substrate 15 
ER    Endoplasmic Reticulum 
ERC    Endocytic Recycling Compartment 
ESCRT                                        Endosomal Sorting Complexes Required for Transport 
FBS    Fetal Bovine Serum 
FCHo                                          F-BAR Domain-Containing Fer/Cip4 Homology Domain-Only                  
                                                    Proteins 
Fer1L5                Fer-1-Like-5 
Floxed (fl)   Flanked by LoxP Sites 
GAPs                                           GTPase Activating Proteins 
GEFs                                           Guanine Nucleotide Exchange Factors  
GLUT4                                       Glucose Transporter 4 
GPCRs                                        G protein-Coupled Receptor  
GTP    Guanosine Triphosphate 
GTPase                GTP Hydrolysis Enzyme 
HBV                                            Hepatitis B Virus  
HIV                                             Human Immunodeficiency Virus 
HSC70                                        Heat Shock Cognate 70 
ICAM-I                                       Intercellular Adhesion Molecule 1 
IFT                                              Essential Intraflagellar Transport  
xiv 
 
IS                                                Immunological Synapse  
KCa2.3 Small Conductance Ca2+-Activated K+ Channel Protein 
LFA-1                                         Lymphocyte Function-Associated 1 
LN                                               Lymph Nodes 
MEFs                                          Mouse Embryonic Fibroblasts 
MHC-I                                        Major Histocompatibility Complex-I 
MHC-II                                       Major Histocompatibility Complex-II 
MICAL-L1                                 Molecules Interacting with CasL-Like1 
MOG                                           Myelin Oligodendrocyte Glycoprotein 
MVB                                           Multi-Vesicular Bodies  
NCX    Na/Ca Exchanger 
NgCAM   L1/Neuron-Glia Cell Adhesion Molecule 
NIH    National Institutes of Health 
NPF                                             Asparagine-Proline-Phenylalanine  
N-terminal   At the Amine-Terminus 
4-OHT                                         4-Hydroxytamoxifen 
PA                                               Phosphatidic Acid 
PBS    Phosphate-Buffered Saline 
PCR    Polymerase Chain Reaction 
PCDH 15                                    Protocadherin 15                    
PI (4, 5) P2                                 Phosphatidylinositol-4, 5-Bisphosphate 
PIKfyve kinase                           Phosphoinositide kinase, Five-type Zinc Finger Containing  
PKCƟ                                         Protein Kinase C-Ɵ 
PLCY                                          Phospholipase C-y 
xv 
 
pSMAC                                       Peripheral SMAC  
PtdIns (3) P                                 Phosphatidylinositol-3Phosphate 
PtdIns(3,5)P2                              Phosphatidylinositol 3,5-Bisphosphate  
Rab    Ras-Like in Rat Brain 
Rab11-FIP2   Rab11 Family-Interacting Protein 
RE    Recycling Endosomes 
Rme-1                Receptor-Mediated Endocytosis Protein 1 
RNA    Ribonucleic Acid 
RTKs                                           Receptor Tyrosine Kinases  
SDS-PAGE   Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
SH3 domain   Src Homology 3 Domain 
SHH                                            Sonic Hedgehog 
SNAP                                          Synaptosomal-Associated Protein 
SNARE                                       Soluble N-Ethylmaleimide-Sensitive Fusion Factor Attachment  
                                                    Protein Receptors 
SNX    Sorting Nexins 
SP                                               Single Positive 
TAMs                                          Immunoreceptor Tyrosine-Activation Motifs 
t1/2    Half-Life 
TBST    Tris-Buffered Saline with Tween-20 
TCRs                                           T-cell Antigen Receptor 
TfR    Transferrin Receptor 
TGN    Trans-Golgi Network 
TSG                                             Tumor susceptibility gene  
xvi 
 
TMA                                            Renal Thrombotic Microangiopathy 
Unc119                                        Uncoordinated 119 Protein 
VS                                                Virological Synapses  
WB    Western Blot 


















































1. Endocytic Trafficking 
1.1 Overview 
Endocytic trafficking is an essential cellular process that has been evolutionarily conserved, 
from yeast to humans, with minor changes and specifications depending on the species.  The 
endocytic trafficking is a fundamentally complex system extensively used in physiologically 
crucial processes such as cell migration (Maritzen, Schachtner, & Legler, 2015; Paul, Jacquemet, 
& Caswell, 2015), receptor turnover (Irannejad, Tsvetanova, Lobingier, & von Zastrow, 2015), 
cell signaling (Barbieri, Di Fiore, & Sigismund, 2016; Irannejad et al., 2015; Platta & Stenmark, 
2011; Villasenor, Kalaidzidis, & Zerial, 2016), and cell-to-cell communication (Onnis, Finetti, & 
Baldari, 2016). It is also used in other pathways such as pathogen invasion (Kulpa et al., 2013; 
Pirooz et al., 2014; Takeuchi, Furuta, & Amano, 2011), cell division (Chesneau et al., 2012; 
Schweitzer, Sedgwick, & D'Souza-Schorey, 2011), and membrane remodeling (Matsubayashi, 
Coulson-Gilmer, & Millard, 2015).  It is important to mention that mis-regulation of endocytic 
trafficking is linked to different diseases including chronic hepatitis B virus (HBV) infections 
(Macovei, Petrareanu, Lazar, Florian, & Branza-Nichita, 2013; Watanabe et al., 2007), cancer 
(Mellman & Yarden, 2013; Mosesson, Mills, & Yarden, 2008), HIV infection (Kulpa et al., 
2013), and autoimmune diseases (Iglesias-Bartolome et al., 2009).  Therefore, understanding how 
this complex system works is of great interest in basic and clinical immunology. 
Directed cell migration is an important phenomenon in embryonic development (Keller, 
2002; Petrie, Doyle, & Yamada, 2009; Wallingford, Fraser, & Harland, 2002), during metastasis 
(Etienne-Manneville, 2008; Petrie et al., 2009) and during immune responses to pathogens or 
transformed cells (Petrie et al., 2009).  For instance, immune cells are known to circulate in the 
blood and through chemotactic gradients released during inflammation to migrate to the site of 
infection.  This very specific extravasation is achieved with the help of chemokine receptors, 
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growth factor receptors, and adhesive integrins (Maritzen et al., 2015). Integrins are one of the 
most important molecules required for, and are in the center of, cell migration.  
Recent studies have shown that endocytic trafficking can regulate integrin functions. 
Integrins are known to continually and rapidly internalize and recycle back to the plasma 
membrane.  For instance, some integrins were shown to internalize almost all their surface pool in 
just 30 minutes (Paul et al., 2015) and with a low degradation rate, most recycled back to the cell 
surface. This is important because as cells migrate, they form a rear and a front part, causing 
integrins to act as “feet” that allow the cells to move forward. It has been suggested that migrating 
cells use the process of endocytosis to move a pool of integrin “feet” from the rear of the cells to 
re-distribute them through exocytosis or by recycling them to the front part of cells to cause the 
forward movement (Paul et al., 2015).  Other work has shown that this directional trafficking of 
integrins actually happens in three different ways, in which they can be trafficked from the front 
to the front, from the front to the rear of the cells, and from the perinuclear region to the rear of 
the cells (Paul et al., 2015).  Endocytosis of integrin does not only promote the disassembly of 
adhesion, but it also contributes to the formation of adhesion reassembly by segregating a pool of 
integrins that can be recycled where new adhesions have to be made (site of action) (Paul et al., 
2015).  Lymphocytes use LFA-1 as their main integrin.  The interaction between LFA-1 and its 
ligand, ICAM, allows T-cells to migrate into peripheral lymph nodes and to interact with antigen 
presenting cells (APCs) for T-cell activation (Evans et al., 2009). However, beside integrin, T-
cells also need other receptors (such as co-stimulatory and co-inhibitory receptors and antigen 
specific receptors) for proper immune response.  All of these receptors are strictly regulated by 
endocytic trafficking.  
Immune cells have to maintain a proper balance between receptors on their cell surface and in 
the intracellular pool to function properly.  Hence, they have to regulate and balance the rate of 
internalization, degradation, recycling and synthesis of new receptors. In most cases, the fate of 
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most receptors is determined by the status of their signaling. Receptor signaling begins at the 
plasma membrane; however, cells have found a way not only to sustain it, but also to terminate it 
through the process of endocytic trafficking (Irannejad et al., 2015).  After ligand binding, 
receptors get activated mainly through phosphorylation of their cytoplasmic domain(s), which 
leads to activation of signaling cascades that eventually leads to different outcomes such as cell 
proliferation, survival, etc.  Ligand binding induces internalization of receptors.  These receptors 
go from the plasma membrane to early endosomes (EE) where they are sorted to either go to the 
lysosomes for signal termination or go back to the cell surface for re-stimulation.  It is well-
established that after internalization, a percentage of signaling receptors go from the EE to the 
multi-vesicular bodies (MVB) where they get sorted to go to the lysosome for either receptor-
ligand degradation or for ligand degradation (Villasenor et al., 2016).  Research also shows that 
another percentage of signaling receptors go from the EE to the cell surface using the fast route or 
the slow recycling route in which receptors go from the EE to recycling endosomes (RE) first and 
then back to the cell surface.  All these steps are strictly regulated by families of endocytic 
trafficking regulators such as Rabs and EHD protein families that will be discussed later.  
Endocytosis is important for segregating a pool of signaling receptors from the plasma 
membrane to the intracellular milieu to make space for new receptors and to allow signaling 
termination. Endocytosis also creates endosomes with pools of receptors that are ready to go back 
to the cell surface to sustain signaling at the cell surface and those that can act as a platform of 
intracellular signaling (Barbieri et al., 2016).  Research has shown that receptors are able to 
continue signaling even inside endosomes in the intracellular milieu.  In T-cells, internalized 
TCRs have been shown to continue signaling in endosomes, therefore expanding the overall time 
of sustained signaling (Yudushkin & Vale, 2010).  
The endocytic trafficking is important in cell-to-cell communication especially among 
immune cells.  Research has shown that during contact between a T-cell and an antigen 
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presenting cell (APC) or a target cell (which can be a transformed cell), they form a contact site 
called the immunological synapse (IS). 
The IS has been shown to be not only a site of intense internalization and recycling, but also 
of directed secretions of cytokines, granzymes, microvesicles, and exosomes (Gutierrez-Vazquez, 
Villarroya-Beltri, Mittelbrunn, & Sanchez-Madrid, 2013). Exosomes in particular, have been 
shown to be bidirectional. Various studies have shown exosomes from APCs endocytosed in T-
cells and vice versa. Other studies have also suggested that when engaged T-cell antigen 
receptors (TCRs) are internalized, some take with them the antigenic peptide or the pMHC inside 
the endosomes and when they are recycled, some of those are re-expressed on the cell surface of 
the T-cells.  Re-expressed antigenic peptides or pMHC can act as APCs in those regions and 
activate other T-cells (a process called cross-dressing) (Campana, De Pasquale, Carrega, 
Ferlazzo, & Bonaccorsi, 2015; Game, Rogers, & Lechler, 2005; Tatari-Calderone, Semnani, 
Nutman, Schlom, & Sabzevari, 2002). Other exosomes carry with them other important 
molecules including small RNAs that were shown to change T-cell profiles (Gutierrez-Vazquez et 
al., 2013).  
In addition, cell-to-cell communication is also exploited by certain pathogens. HIV for 
example uses the virological synapse (VS), which is very similar to the IS, as a way to replicate 
itself. Infected CD4+ T-cells form VS with other immune cells, including healthy CD4+ T-cells; 
vesicles containing HIV have been shown to be secreted into the VS and endocytosed by target 
cells. This newly infected cell can then form other VS with other healthy cells and spread the 
virus (Alvarez, Barria, & Chen, 2014). 
Regardless of which way the cell chooses to utilize the endocytic trafficking pathway, they all 
involve the internalization of materials through the invagination of the plasma membrane into the 
cytoplasmic milieu. This mainly involves the pinching of the plasma membrane, and then the 
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release of the endosome containing internalized materials into the cytoplasmic milieu. Once in the 
cytoplasm, depending on their fate, the materials are sorted into specific endosomes. In the case 
of receptors, they either can go to the lysosomes for degradation or can recycle back to the cell 
surface for other rounds of activation. 
1.2 Routes of Endocytosis 
Cells use endocytic trafficking for many functions, including the internalization of 
receptors and uptake of nutrients, ligands, viruses and molecules. Cells use different routes to 
endocytose materials that include the clathrin-dependent pathway and the clathrin-independent 
pathway. The clathrin-independent pathway is further classified into caveolin-dependent, and 
clathrin-and caveolin-independent, ARF6 endocytosis (Fig 1.1).  Regardless of the pathway, the 
internalized receptors enter the early endosome (EE) where they are sorted for either traffic into 
late endosome/MVB and lysosome or for recycling back to the cell surface. The latter proceeds 
either through the fast recycling route (directly to the plasma membrane) or through the slow 
recycling route via the endocytic recycling compartment (also called recycling endosome) (Gould 
& Lippincott-Schwartz, 2009; Jovic, Sharma, Rahajeng, & Caplan, 2010) (Fig 1.1).   
Clathrin-mediated endocytosis (CME) is the most studied form of entry into the 
cytoplasm and it is used by all eukaryotic cells. This pathway has been extensively studied for the 
traffic of receptor tyrosine kinases (RTKs) such as EGFR and for G protein-coupled receptor 
(GPCRs). CME is defined by uptake of materials from the plasma membrane into the cytoplasm 
of cells through clathrin-coated vesicles. Five steps lead to the formation of a clathrin-coated 
vesicle (CCV).  They include initiation (nucleation), cargo selection, coat assembly, scission, and 
uncoating (McMahon & Boucrot, 2011). Nucleation is the first step in CCV formation, in which a 
particular site in the plasma membrane is marked for invagination; it also involves the 
recruitment of clathrin machinery to the site. The membrane-sculpting F-BAR domain-
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containing FCHo1 and 2 (FCHo1/2) proteins, together with other proteins, function as 
nucleator of clathrin-coated pits (CCP). FCHo1/2 bind to the plasma membrane to mark the site 
of CCV formation and recruit the scaffolding epidermal growth factor receptor substrate 15 
(eps15) and intersectin (Henne et al., 2007; McMahon & Boucrot, 2011; Pechstein et al., 2010) 
which in turn recruit AP-2. This complex is able to form membrane curvature even before the 
recruitment of clathrin (Henne et al., 2007; Henne et al., 2010; McMahon & Boucrot, 2011). 
Other proteins such as SGIP1 (Henne et al., 2010) and other adaptors besides AP-2 are also 
involved in this step, and include AP180 and clathrin assembly lymphoid myeloid leukemia 
(CALM) (Daumke, Roux, & Haucke, 2014). All of these initiation proteins associate at specific 
sites in the plasma membrane that are enriched in phosphatidylinositol-4, 5-bisphosphate [PI (4, 
5) P2] (Di Paolo & De Camilli, 2006) and mark those areas for clathrin recruitment and assembly.  
The next step is the cargo selection in which cargos with specific sequence are 
recognized and bound to AP-2 and other cargo-specific adaptor proteins. CME is the only 
endocytic pathway with very well-characterized cargos. It has been shown that the destination of 
individual receptors and other membrane proteins depend on their intrinsic sequence-based signal 
motif located in the cytoplasmic domain (Traub, 2003). These internalization signals are required 
for transmembrane protein fast endocytosis (Traub, 2003). Transmembrane proteins are known to 
bind directly to the µ2 subunit of AP-2 (4 subunits: α and β2 adaptins, µ2 and the σ2) (Ohno et 
al., 1995).  AP-2 recognizes and interacts with cargos containing sequences such as the YXXØ 
(where X is any amino acid and Ø is a bulky hydrophobic residue) and [DE]XXXL[LI] dileucine 
signals (Traub, 2003).  Some cargos may also contain motifs such as the Asn-Pro-X-Tyr sequence 
(NPXY) that are recognized by other clathrin adaptor proteins (Traub, 2003). 
After the selection of the cargos that are to be internalized, clathrin triskelia are then 
recruited from the cytosol of the cell to the site of the CCP on the plasma membrane by AP-2 and 
other accessory adaptor proteins to help form the CCV.  Clathrin triskelia concentrate in those 
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CCP forming clathrin lattice; their polymerization stabilizes the curvature, cargo-specific 
adaptors and curvature effectors such as eps15 and intersectin.  After their maturation, the CCV 
pinch off from the plasma membrane through the help of dynamin, recruited by BAR domain-
containing proteins.  These proteins have a preference in forming the curvature of necks for the 
forming vesicles, and are suggested to help in the process of neck formation of the vesicles that 
dynamin pinches off. These proteins include amphiphysin, endophilin, and sorting nexin 9 
(SNX9) (McMahon & Boucrot, 2011; Meinecke et al., 2013).  
After the scission by dynamin, the newly formed CCV is found in the cytosol, but before 
it can fuse with the early endosomes, they have to be stripped of their coats.  CCVs go through a 
process of coat disassembly, by which the clathrin lattices go from an arranged conformation to 
individual triskelia by the help of the ATPase heat shock cognate 70 (HSC70) and its cofactor 
auxilin (Krantz et al., 2013). The triskelia are recycled for other CCV formation. The uncoated 
internalized endosome can now fuse with the early endosome where the cargos are sorted 









Figure 1.1:  Pathways of Endocytosis. Different routes of endocytosis include the clathrin-
dependent (CME), caveolin-dependent (CavME), and the clathrin- and caveolin- independent 
internalization. Regardless of the route of internalization, the budded vesicle fuses with the EE 
where they are sorted to either recycle back to the cell surface or go to the late endosome for 




In addition to CME, cells also use other pathways for entry of materials into the 
cytoplasm that are called clathrin-independent endocytosis (CIE). CIE includes mainly caveolae-
dependent (clathrin-independent) endocytosis and both clathrin- and caveolae- independent 
endocytosis called the Arf6 endocytosis (Maldonado-Baez, Williamson, & Donaldson, 2013). 
Caveolae-mediated endocytosis (CavME) is defined as flask plasma membrane 
invagination of 60-80 nm diameters that are abundant in most eukaryotic cells. Caveolae are 
associated with cholesterol-rich lipid-raft domains and some glycosphingolipids and 
sphingomyelins (Parton & Simons, 2007); they are used more extensively in some cells (such as 
adipocytes and endothelial cells) than others. Caveolae pits are made of proteins from the 
caveolin family, with Caveolin-1 (Cav1) being the most important. These proteins have been 
shown to work in association with the cavins family of proteins (Elkin, Lakoduk, & Schmid, 
2016; Parton & Simons, 2007; Parton & del Pozo, 2013). 
CavME is different from other CIE in a couple of ways: i) CavME do not show a defined 
coat structure (electron dense coat) as seen in CIE, nor show progression of neck formation 
during cargo internalization; and ii) unlike clathrin, caveolae are differentially expressed in some 
tissues and cells. Caveolae have been shown to make up about 50% of the plasma membrane 
surface in cells such as adipocytes and endothelial cells. Even within a particular cell, caveolae 
were preferentially shown to concentrate more in one area than another (Parton & del Pozo, 
2013). For example, Cav1 homo-oligomers were shown to accumulate at the apical site while 
Cav1 and Cav2 hetero-oligomers were accumulated at the basolateral side of epithelial cells. In 
addition, Cav1 was shown to concentrate at the rear end of endothelial cells during planar 
movement (migration) and to co-localize with caveolae (Parat, Anand-Apte, & Fox, 2003).  
It is believed that caveolin oligomers traffic to the plasma membrane. Cavin proteins are 
also recruited there and stabilize caveolin oligomers. What recruits cavin to the caveolae site is 
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not clear, but interactions with caveolae and CAV1 may play a significant role. CavME is less 
defined compared to the CME; however, recent studies have linked it to signal regulation, 
receptor localization and trafficking, and regulation of lipids trafficking and metabolism (Parton 
& del Pozo, 2013). 
As more studies have emerged on understanding the entry of materials into the cytosol of 
cells, it has become clear that other alternative routes of entry exist besides CME and caveolae-
dependent pathways. These include newly discovered clathrin- and caveolae-independent 
endocytosis with pits containing flotillins (e.g. uptake of cholera toxin and endocytosis of 
glycosylphosphatidylinositol (GPI)-linked proteins) (Glebov, Bright, & Nichols, 2006), pathways 
that involve small GTPases Rac1 and Cdc42, endophilin-dynamin- RhoA-dependent pathway 
(e.g. Interleukin- 2 receptor endocytosis) (Lamaze et al., 2001), and the pathways that requires the 
small GTPase called Arf6 (e.g. MHC-I) (Elkin et al., 2016). 
Most cells use both clathrin-mediated and clathrin-independent endocytosis at the same 
time depending on the need and the kind of receptor transported. Such communication was 
observed in the case of Rab35 which is transported by the CME, but is required for the transport 
of cargos through CIE (Dutta & Donaldson, 2015).  
1.3 Endocytic Trafficking Endosomes 
Regardless of the route of endocytosis, all vesicles containing internalized materials end 
up in the EE where they are sorted to go to the lysosomes or to go back to the cell surface through 
the fast route (directly to the cell surface) or through the slow route using the RE. The EE is a 
very dynamic structure with the capacity of undergoing homotypic fusion.  The EE is composed 
of micro-domains of tubule extensions of approximately 60 nm in diameter and large vesicles of 
approximately 400 nm in diameter. The EEs are each specialized for the sorting of specific 
cargoes within minutes after their internalization, according to their fates, into sub-domains that 
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will sort them to the RE for recycling back to the plasma membrane or to the MVB for 
degradation.  The acidification of vesicles from these two different sub-domains also varies with 
approximate pH ranging from 6.2 to 5.5 in the lumen of MVB and a pH of 6.5 in the tubular 
recycling endosomes (Jovic et al., 2010). In addition, the pH in the lumen of EE is approximately 
6.3-6.8 and allows the dissociation of most ligands from their receptors. An example of this is 
seen in the case of the low density lipoprotein receptor that dissociates from its ligand (low 
density lipoprotein) in the EE after internalization, and the receptor is sorted into a tubular sub-
domain for recycling while the ligand is sorted into the larger vesicle sub-domain for degradation. 
The opposite is seen in the case of ligand-bound EGFR that is sorted together with the ligand into 
the more circular or large vesicle sub-domain for degradation. 
Internalized materials, including signaling receptors that are targeted to go back to the 
cell surface, are sorted into micro-domains in the EE that are constantly forming tubules.  Those 
tubules containing cargo are labeled with Rab4 and Rab5 and, can either go back directly to the 
plasma membrane using the fast route or can fuse with  or differentiate into recycling endosomes 
(RE) to go through the slow route (Jovic et al., 2010).  When stained with Rab11, for example, 
REs showed perinuclear localization. A good example of a signaling receptor that goes through 
both recycling pathway is the transferrin receptor (TfR).   Studies that measured the recycling of 
TfR confirmed the existence of a slow (t1/2=15-30 minutes) and a fast route (t1/2= 5 minutes) for 
recycling with different kinetics (Hopkins & Trowbridge, 1983; Swiatecka-Urban, 2013). This 
tubular compartment is usually marked by the presence of Rab11 and/or EHD1, which will be 
discussed in another sub-chapter. 
The RE is not only important for the recycling of receptors, but it is crucial to sustain 
signaling at the plasma membrane.  It is required for antigen presentation by APCs, for the 
maintenance of the immunological synapse necessary for proper immune responses, for the 
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maintenance of cell polarity in polarized cells, for cell division, for migration, and for neuronal 
synapse and neuron survival. 
Receptors in the EE to be degraded have a sorting signal that allows them to be targeted to 
the lysosome. For signaling receptors including the epidermal growth factor receptor (EGFR), a 
mono-ubiquitination of one or more tyrosine residues in their cytoplasmic domain is required for 
their targeting to the lysosomes.  It is believed that receptors targeted to the lysosome accumulate 
in areas in the EE that are rich in flat clathrin lattice. The hepatocyte growth factor-regulated 
tyrosine kinase substrate (Hrs) in the EE binds ubiquitinated cargo, clathrin in the flat lattice and 
other proteins such as the tumor susceptibility gene (Tsg)101 subunit of endosomal sorting 
complexes required for transport (ESCRT-I), that in turn recruit ESCRT-II and ESCRT-III. 
Together they bud off the EE and form the multivesicular bodies (MVB), which are somewhat 
rounded and will then fuse to the lysosome for the degradation of the signaling receptor (Jovic et 
al., 2010).   
Another pathway that bridges from the EE is the retrograde transport to the Golgi complex. 
Cargoes from the EE targeted to the trans-Golgi network (TGN) are sorted into tubular sub-
domains similar to those used for the recycling. The differences between these two tubular sub-
domains are that those used for the TGN are from more mature EE, are enriched with 
SNX1/sortilin and show the presence of the retromer machinery with a high concentration of 
phosphatidylinositol 3, 5-bisphosphate (PtdIns (3, 5) P2) generated by phosphoinositide kinase, 
five-type zinc finger containing (PIKfyve kinase) (Jovic et al., 2010; Mari et al., 2008; Rutherford 
et al., 2006). Caveolin-1 serves as a marker of endosomes in the transport of cargo from the 
plasma membrane to the Golgi complex (Nichols, 2002). 
EEs are not just important in sorting and directing cargoes to specific endosomes for their 
fate, they are also important in signaling. Different GPCRs, such as thyroid-stimulating hormone 
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receptor, have been shown to regulate signaling of MAPK and PI3K signaling pathway and the 
production of secondary passengers such as cAMP while inside EE (Calebiro et al., 2009). 
Recent studies have shown other kinds of recycling beside the typical slow and fast route of 
recycling, well-described with the traffic of TfR. It was shown that the RE that recycles TfR is 
different than the more tubular RE that are seen in the recycling of CIE cargoes such as MHC-I 
(Swiatecka-Urban, 2013). Although, in both cases, these endosomes are positive for some similar 
markers such as Rab11; they also have more specific markers such as Arf6 that mark them more 
specifically for one type of cargo than the other. Cells have to maintain a proper balance between 
the rates of internalization, degradation, recycling and synthesis for normal function. The 
endocytic trafficking pathways involves the uptake of various materials including receptors 
(which were described above), nutrients, pathogens, and more. Despite the most common and 
well-studied pathways of endocytic trafficking mentioned above, other pathways exist such as 
phagocytosis of large particles (used mainly by APCs), pinocytosis, and trogocytosis that are all 
strictly regulated and used by cells for various reasons. 
2. Regulators of the Endocytic Trafficking  
2.1. Rab GTPases. 
Endocytic trafficking is a very complex process with defined steps that are strictly 
regulated by a small number of protein families including the Ras-associated binding (Rab) 
proteins.  Rab proteins are evolutionarily conserved proteins that are present in organisms ranging 
from yeast to humans.  For many decades, the Rab proteins have been shown to be the master 
regulators of different steps of the endocytic traffic including the transport to the cell surface, to 
the MVB then to the lysosomes for degradation, and transport to and from the TGN.  Rabs are 
small (21-25 kDa) monomeric GTP-binding proteins that cycle between the active form (GTP-
bound) and the inactive form (GDP-bound).  In their GTP-bound/active state, Rab proteins 
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localize to intracellular membrane where they have been shown to recruit and interact with their 
effectors. It is through these effectors that Rab proteins functions.  Upstream regulators called the 
guanine nucleotide exchange factors (GEFs) in the cytoplasmic surface of different membranes-
bound organelles control the active or GTP-bound state of Rabs. GTPase activating proteins 
(GAPs) (Bhuin & Roy, 2014; Jovic et al., 2010; Wandinger-Ness & Zerial, 2014) regulated the 
inactive or GDP-bound state of Rabs, causing the hydrolysis of the Rab-GTP complex, 
converting it into Rab-GDP, and causing its release from the target membrane to the cytosol. 
Rab proteins that are known to localize in the EE include Rab5, Rab4, and most recently 
classified Rab35; all playing different functions in the EE. Rab5 regulate the entry of vesicles 
containing internalized cargoes from the plasma membrane to the EE. Rab5 is also important for 
the generation of phosphatidylinositol-3 phosphate (PtdIns (3) P) lipids, for homotypic fusion and 
for the movement of sub-domains of EE on actin and microtubules tracks.  Some of Rab5 
effectors include PtdIns (3) P-Kinase/h VPS34/p150 (VPS34), early endosomal antigen-1 
(EEA1), rabenosyn-5, and APPL1 and APPL2 (Jovic et al., 2010). 
Rab4 and Rab35 are regulators of the traffic pathway that localize in the EE. Both Rab4 
and Rab35 regulate the transport or exit of constitutively and specialized recycling cargos from 
the EE directly back to the plasma membrane using the fast route. In addition, Rab4 is shown to 
regulate the exit of cargo from the EE to the RE for slow recycling. Key effectors of Rab4 include 
rabenosyn-5, rabaptin-4, rabaptin-5 and rabaptin-5β.  Rab35 is more associated with the recycling 
of cargoes that were internalized through CIE. Cargoes trafficking in Arf6-positive endosomes 
are positive for Rab35, but not Rab4, indicating that Rab35 is more associated with the recycling 
of cargo from CIE (Chesneau et al., 2012; Etienne-Manneville, 2008; Walseng, Bakke, & Roche, 
2008).  Other Rabs (less studied) that also localize at the EE include Rab10, Rab14, Rab21 and 
Rab22 (Jovic et al., 2010).  
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Rab7 and Rab9 regulate the transport in the late endosome. Rab7 is now commonly used 
as a marker for late endosomes that mature into or fuse with the lysosomes. Rab9 has been shown 
to be more associated with the transport from late endosomes to the trans-Golgi. Another 
important group of Rabs is the Rab11 protein.  Rab11, together with Rab4, and Rab35 mediate 
the recycling of cargo to the cell surface; however, Rab11 localizes in the RE and is more specific 
for cargoes going through the slow recycling. Rab11 regulate the recycling of cargoes from the 
EE and the transport of cargoes from the Golgi complex (Goldenring, 2015; Jovic et al., 2010). 
Rab11 effectors include rabphilin11, Rab11 binding protein (Rab11 BP), family interacting 
protein2 (FIP2), FIP3, FIP4, secretory protein 15 (Sec15), and Rab interacting protein 11(RIP11). 
Other regulators of the endocytic trafficking in addition to the Rab family of GTPases are within, 
the EHD-containing protein family (Zhang, Naslavsky, & Caplan, 2012).  
2.2. EH Domain-Containing Protein Family 
The EH domain was originally identified in 1993, as a three repeat sequence in the NH2-
terminal of eps15 (EGFR pathway substrate clone.15) (Fazioli, Minichiello, Matoskova, Wong, & 
Di Fiore, 1993), and later on the same repeats were identified in another EGFR substrate called 
eps15R (Coda et al., 1998).  Since then, the number of proteins identified as containing this 
domain has increased, and is now estimated to be over 50 EH domain- containing proteins 
discovered, that include intersectin, Resps1, POB1, END3P and others (Fig 1.2).  This domain is 
important for protein-protein interaction and has been observed in organisms ranging from yeast 
to humans.  Most EH domain-containing proteins have more than one repeat of this domain in 
their NH2 terminus, but neither the position of this domain nor the number of repeats appears to 
be a requirement for function (Fig 1.2). The EH domain has a preference of binding to proteins 
with asparagine-proline-phenylalanine (NPF) motifs such as Numb I. Studies have also shown 
that the positions of amino acids around this motif are important for this protein-protein 
interaction (Fazioli et al., 1993; Santolini, Salcini, Kay, Yamabhai, & Di Fiore, 1999).   
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Most of the well-studied EH domain-containing proteins such as eps15 and intersectin are 
mainly involved in the early steps of endocytosis and are shown to be critical regulators of 
endocytic traffic. In addition to the NH2-terminal EH domain-containing proteins, a family of 
proteins (as a sub-family of the EH domain proteins) was discovered that expresses only one 
repeat of the EH domain located in the COOH-terminus and, is also involved in the endocytic 













Figure 1.2: Architecture of EH Domain- Containing Proteins. There are now over 50 proteins 
in this family of EH domain-containing proteins.  The structures of a few of them are shown here. 
Most of them contain more than one repeat of the EH-domain on their N-terminus. The EH-
domain is for their interaction with other proteins that contain NPF motifs. [(Santolini et al., 




3. EHD Protein Family 
3.1 EHD Protein Structure 
EHDs are evolutionarily conserved proteins that include four members (EHD1-4) in 
mammals and one member in Caenorhabditis elegans, Drosophila melanogaster, plants such as 
Arabidopsis thaliana, and in eukaryotic parasites such as Plasmodium falciparum, Leishmania 
major and Entamoeba histolytica (Daumke et al., 2007).  In mammals, EHD1 was the first 
member characterized, before the discovery of the other three members, EHD2, EHD3, and 
EHD4 (Mintz et al., 1999; Pohl et al., 2000). Based on nucleotide sequence alignment, EHD1 and 
EHD2 have about 74% homology, up to 82% homology between EHD1 and EHD3, and up to 
76% homology between EHD1 and EHD4 (Pohl et al., 2000). This family of proteins also has 
very similar amino acid sequence and protein structure. These results suggest that EHD3 is the 
most similar to EHD1 compared to the other members. Genes encoding these proteins were 
mapped to different chromosomes with EHD1 to 11q13, EHD2 to 19q 13.3, EHD3 to 2q21 and 
EHD4 to 15q11.1 (Pohl et al., 2000). 
EHD proteins are ubiquitously expressed in most mouse organs analyzed, but show 
differences in expression levels in various tissues. For example, EHD1 is highly expressed in 
lung, spleen and in testis, but low in the kidney and liver. EHD2 is high in lung, mammary 
glands, and fat tissues, but is either low or not expressed in kidney and in brain. EHD3 has a high 
expression in heart, but has a low expression in the lung and liver. EHD4 is highly expressed in 
the heart and pancreas, but has a low expression in the mammary glands and liver (Mintz et al., 
1999; Pohl et al., 2000).  
  All EHDs have three domains including the EH domain, the helical domain and the P-
loop domain (also called the ATP/GTP-binding site) (Fig 1.3A). The EH domain is used for 
protein-protein interaction and strongly binds to proteins with tripeptide asparagine-proline-
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phenylalanine (NPF) motif followed by two acidic residue (Daumke et al., 2007; Kieken et al., 
2010). These amino acids around the NPF motif have been shown to be critical for binding. A 
conserved positively charged amino acid, lysine 483, is important for the function of the EH 
domain. Mutation of this lysine to glutamic acid had no obvious defect on the structure of the EH 
domain, but it caused a mis-localization of mutant EHD1 from tubular membranes to more 
punctate structures. These results were similar to those seen when the entire EH domain was 
truncated, suggesting a critical role of the EH-phosphoinositide interaction in membrane 
tabulation (Naslavsky, Rahajeng, Chenavas, Sorgen, & Caplan, 2007).   The coiled-coil domain 
(helical domain) is for oligomerization and the P-loop (G-domain) binds and hydrolyzes ATP 
instead of GTP. The P-loop is also required for dimerization and acts as the membrane-binding 
region.  The structure of EHD proteins also shows a linker region that connects the domains that 
proceed the EH domain. The presence of an EH domain in EHDs suggested that they might have 
a role in receptor-mediated endocytosis as shown with other EH domain-containing proteins such 
as eps15 (Mintz et al., 1999). 
Out of the 4 members, EHD2 and EHD4 are the only ones with a three-dimensional 
protein structure resolved; however, the structure of the EH domain of EHD1 has also been 
resolved (Fig 1.3B & Fig 1.4A). Studies on the characterization of the EHD2 structure provided 
evidence that EHD proteins are involved in membrane remodeling in vivo and this task is ATP 
dependent (Daumke et al., 2007). The study showed that EHD proteins have many similarities 
with the dynamin superfamily including the ability to tabulate liposomes in vitro, to oligomerize 
around lipid tubules in ring-like structures, and to hydrolyze nucleotide in response to lipid 
binding (Daumke et al., 2007). Recent studies have characterized the structure of an N-terminally 
truncated, activated EHD4 dimer (Melo et al., 2017). This group also performed a side-by-side 
analysis comparing the non-activated/nonhydrolyzable ATP- bound EHD structure to the 
activated EHD structure (Fig 1.3 and Fig 1.4).   
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While in the cytosol, EHD proteins are in an auto-inhibited conformation, where the N-
terminus is locked in the GTPase domain and the EH domains block assembly. However, once 
recruited into the membrane, different conformational changes allow their functions. In the first 
conformational change/rotation, the N-terminus of EHD proteins is released from the GTPase 
domain; this was suggested to cause the activation of the EHD (Melo et al., 2017). The other 
change is the rotation of the helical domains that adjust the position of the membrane-binding 
site. This rotation seemed to regulate membrane binding. At the same time, this also causes the 
linker to the EH domain to be freed from the GTPase domain. As a consequence, this then causes 
the EH domain to become free compared to their inactive form. This was suggested to resemble 
the interaction of an EH domain with an NPF motif binding protein such as MICAL-L1 (Melo et 
al., 2017). Other conformations permit the formation and stabilization of EHDs oligomerization 
at the membrane, and lead to membrane curvature ((Melo et al., 2017), Fig 1.4).  EHD proteins 
form homo and hetero-oligomers with the exception of EHD2 that appears to form only 
homodimers. Other studies in mammalian cells have shown that EHD1 and EHD3 form homo 
and hetero-oligomers, and EHD1 has been shown to form heterodimers with EHD4 in vivo (Yap, 
Lasiecka, Caplan, & Winckler, 2010). 
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Figure 1.3: Structure s of EHD Proteins. A) Generic structure of EHD proteins showing the 3 
domains including the helical domain, ATP-binding-G-domain, and the EH-domain. B) Dimers 
of EHD2 protein in the presence of a nonhydrolyzable ATP analog adenylyl imidodiphosphate 





















Figure 1.4: Structure of Activated EHD4 Dimers. A) Structure of the ATPγS-bound EHD4ΔN. 
The purified N-terminally truncated EHD4 variant (amino acids 22–541). B) Activation model of 
EHDs. Numbers refer to release of the N-terminus into the membrane (1), rotation of the helical 
domain (2), release of the EH domains from the autoinhibitory site (3), insertion of the KPF-loop 
into the hydrophobic pocket of the GTPase domain (4), membrane binding and oligomerization 








    3.2 Functions of EHD Proteins in vitro and in vivo: 
Since the discovery of all four members of the EHD protein family, interest in studying 
their functions, both in vitro and in vivo, have increased.  EHD1, compared to the other family 
members, is the most studied and well-characterized. EHD1 has been described to regulate the 
transport of various materials including signaling molecules from the early endosomes back to the 
plasma membrane through the recycling endosome (Naslavsky & Caplan, 2011). However, some 
studies associated the function of EHD1 to earlier steps of the endocytic trafficking (such as the 
internalization of receptors) (Naslavsky, Rahajeng, Rapaport, Horowitz, & Caplan, 2007).  EHD1 
was first identified in a genetic screen that was looking for endocytic genes in Caenorhabditis 
elegans. The investigators used a dominant-negative construct with a point mutation near the EH 
domain and showed mis-localization of the endocytic RE and slowing of transferrin receptor 
recycling (George et al., 2007; Lin, Grant, Hirsh, & Maxfield, 2001; Mintz et al., 1999). 
EHD proteins are cytosolic proteins that are recruited to the endosomes through 
interactions with specific lipids such as phosphatidic acid (PA) that are enriched in the endosomal 
membrane.  Recent in vitro studies (Giridharan, Cai, Vitale, Naslavsky, & Caplan, 2013) have 
revealed that PA recruit MICAL-L1 (Molecules Interacting with CasL-Like1) and the F-BAR 
protein Syndapin2 (Syn2, also called PACSIN2), to the RE and form a stable structure that is 
involved in the curvature of the endosomal membrane and tubule formation by Syn2. EHD1 is 
recruited to those tubules through a direct interaction with MICAL-L1. EHD1 also directly 
interacts with Syn 2, so once recruited, EHD1 binds to both MICAL-L1 and Syn2, which then 
performs vesiculation  or scission of the pre-formed tubules (Braun et al., 2005; Giridharan et al., 
2013; Rahajeng, Giridharan, Cai, Naslavsky, & Caplan, 2012; Reinecke, Katafiasz, Naslavsky, & 
Caplan, 2014). EHD1 mainly marks the RE and primarily exhibits perinuclear localization where 
it has been shown to regulate the recycling of various molecules such as TfR, MHC-I, MHC-II, 
β1 Integrin, and GLUT4 ((Caplan et al., 2002; George et al., 2007; Guilherme, Soriano, 
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Furcinitti, & Czech, 2004; Jovic, Naslavsky, Rapaport, Horowitz, & Caplan, 2007; Lin et al., 
2001; Naslavsky & Caplan, 2011; Walseng et al., 2008), Fig 1.5). 
The in vitro studies were instrumental in defining the mechanism of EHD proteins 
functions in the endocytic trafficking pathway. In vivo studies of EHD proteins revealed that 
these proteins are essential in fundamentally and physiologically relevant processes such as eye 
development, embryonic development, muscle formation, and fertility.  The EHD1 null mouse 
was engineered in our laboratory and was found to be embryonically lethal in mice having a 
predominantly B6 background (Bhattacharyya et al., 2016). Embryos from these mice were 
studied in detail and they showed a neural tube closure defect. Further mechanistic investigation 
showed short and stubby cilia with dysregulated ciliary SHH signaling due to a defective 
transport of smoothened (a SHH receptor that was shown to be regulated by EHD1) 
(Bhattacharyya et al., 2016). EHD1 null mice in a mixed 129:B6 background showed eye defects 
including anophthalmia, aphakia, microphthalmia and congenital cataracts (Arya et al., 2015). 
Another study showed that the lamprey I-EHD (conserved EHD1/3 ortholog) was found 
to be enriched at the synaptic release site and to regulate the clathrin/dynamin-dependent synaptic 
vesicle budding and dynamin function (Jakobsson et al., 2011). EHD1 has also been studied in rat 
brains and found to negatively regulate synaptic vesicle exocytosis through binding to a protein 
associated with synaptic vesicle called snapin (Wei et al., 2010). 
EHD proteins have an EH domain that binds target proteins with an NPF motif followed 
by an acidic residue. EHD1 has been shown to directly interact with proteins including, but not 
limited to, Rab11 effector Rab11-FIP2, syndapin 1 and syndapin 2, snapin, SNAP29, rabenosyn-
5, and MICAL-L1.  In addition to its well-known function in the RE, EHD1 has also been shown 









Figure 1.5: Endocytic Trafficking of Signaling Receptors. This diagram has been modified to 
show where in the endocytic trafficking pathway the EHD proteins seem to function. These 
functions are based on various in vitro experiments from different groups and some confirmation 
from some in vivo models. EHD proteins have been shown to play similar and distinct roles in 
different steps of the endocytic trafficking pathway. [Modified from (Scita & Di Fiore, 2010) 





EHD3 is the closest to EHD1 in sequence identity.  EHD3 has been studied in different 
systems in vitro. Those studies have shown that EHD3 regulates the exit of cargos from the EE to 
the RE (Naslavsky, Rahajeng, Sharma, Jovic, & Caplan, 2006) (Fig 1.5). Unlike EHD 1 that was 
shown to cause scission of pre-existing tubules, EHD3 is important in endosomal membrane 
tubulation (Henmi et al., 2016). EHD3 null mice do not have any overt phenotypes. However, 
another group found EHD3 expression level increased during heart failure in large animals such 
as dogs (Gudmundsson et al., 2012). EHD3 null mice also had cardiac abnormalities including 
arrhythmias and blunted response to adrenergic stimulation, and reduced expression of Na/Ca 
exchanger (NCX1) (Curran et al., 2014).  In glioma cancer tissues, EHD3 was found to function 
as a tumor suppressor by controlling cell cycle arrest and apoptosis (Chukkapalli et al., 2014).  
EHD4 is involved in trafficking of the EE and control the exit of cargo from both the RE 
and the late endosomes (Fig 1.5). To demonstrate the role of EHD4 in recycling, the Caplan 
laboratory studied the effect on recycling of TfR and MHC- class I, and  used low-density 
lipoprotein to demonstrate its role in degradation (Sharma, Naslavsky, & Caplan, 2008). In 
neurons, the neurotrophin (NT) family of target-derived growth factors controls neurons’ survival 
in both the periphery and in the CNS by signaling through Trk receptor tyrosine kinase (which 
has ligands such as TrKA, etc.). EHD4, called Pincher in this study, was shown to regulate the 
internalization of TrKA and TrKB, to associate with TrK endosomes in the MVB, and to regulate 
their retrograde transport and signaling by associating with ErK5, a downstream effector of the 
retrograde survival signaling (Valdez et al., 2005).  To demonstrate the role of EHD4 in vivo, our 
laboratory engineered EHD4 null mice.  These mice showed that EHD4 was required for normal 
pre-pubertal testis size in the male. These EHD4 null males had reduced fertility (George et al., 
2010). As seen with other EHD whole body knockout systems, EHD1 expression was high in 
adult mice and, we believe, compensated for the loss of EHD4 in some organs. 
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EHD proteins have been shown to have both shared and distinct roles in endocytic 
trafficking (George et al., 2007), and these have caused their genetic studies to be confounded due 
to their compensatory functions.  While EHD3 null mice have no obvious phenotype, EHD3 and 
EHD4 double knockout mice had smaller, pale kidneys, died at very young age (between 3-
24weeks), and developed renal thrombotic microangiopathy (TMA)-like glomerular lesions 
(George et al., 2011). Cadherin -23 (CDH23) and protocadherin 15 (PCDH15), members of the 
cadherin superfamily, form some of the extracellular filaments that connect stereocilia and 
kinocilium of a hair cell into a bundle (Muller, 2008). Deletion of CDH23 and PDH15 genes has 
been associated with deafness.  A study showed that EHD4 interacts with CDH23 in hair cells; 
however, EHD4 null showed no defect in hearing suggesting a compensatory function for EHD1 
as these mice showed a 2-fold increase in EHD1 expression (Sengupta et al., 2009). 
EHD2 is the most distinct of all the other EHD proteins.  EHD1, EHD3 and EHD4 are 
located on intracellular tubular/vesicular membranes, while EHD2 is located to the cytoplasmic 
interface of the plasma membrane. All EHDs form hetero-oligomers, except for EHD2 that only 
forms homo-oligomers.  EHD1 protein localization to the membrane depends on interactions with 
MICAL-L1 and with phosphatidylinositol lipids, as the mutation in lysine 483 inhibits EHD1 
localization to the tubular structures (Naslavsky et al., 2007). However, the localization of EHD2 
to the plasma membrane is regulated by its interaction with phospholipid PIP2 and is independent 
of actin microfilaments (Simone, Caplan, & Naslavsky, 2013).  Based on its localization on the 
cytoplasmic side of the plasma membrane and its association with phospholipids, studies were 
done to determine whether EHD2 has any role in the early steps of internalization such as vesicle 
formation.  EHD2 was identified as a third structural element or component of the caveolae at the 
plasma membrane and is involved in controlling the stability and turnover of the caveolae.  EHD2 
was also shown to interact directly with cavin1 and pacsin2/Syn2, such that its deletion resulted 
in more dynamic and short-lived caveolae (Moren et al., 2012).  
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EHD2 localization in the plasma membrane suggested possible actin interaction with 
actin. One study connected EHD2 to the actin cytoskeleton through its interaction with EHBP1. 
EHBP1 has a CH domain similar to that of the type 1 CH domain of α-actin, which binds F-actin 
(Guilherme et al., 2004). Another study showed that EHD2 interacts with Nek3 and is associated 
with Vav1, a Nek3-regulated GEF for Rho GTPases.  Since Vav1 regulates Rac1 activity, this 
study suggested that EHD2 regulates the traffic from the plasma membrane by controlling Rac1 
activity (Benjamin et al., 2011).  EHD2 is highly expressed in fat, and regulates the 
internalization of Glut4 in adipocytes (Guilherme et al., 2004).  EHD2 is involved in other 
pathways besides the internalization of material from the plasma membrane (Fig 1.5). It directly 
binds to the second C2 domain of myoferlin and regulate myoblast fusion (Doherty et al., 2008) 
and, translocate to the nucleus as well as suppresses transcription (Pekar et al., 2012) and 
accumulates at the site of injury in human myotubes during membrane repair processes (Marg et 
al., 2012). 
The EHD protein family is involved in various steps of endocytic trafficking including 
internalization, endosomal sorting (at the early endosome, late endosome, and recycling 
endosome), and retrograde transport.  EHD proteins regulate the process as of cell migration, 
embryonic development, muscle size regulation, fertility, synaptic release in neurons, and 
receptor trafficking from the plasma membrane to their designated destination, and have more 
recently been associated with diseases such as cancer and neurological disorders such as 
Alzheimer’s (Buggia-Prevot et al., 2013; Chukkapalli et al., 2014). However, although studies 
have shown the expression of EHD proteins in lymphoid tissues such as the spleen, prior to the 





4. T-cell Functions 
4.1 Overview of T-cell Development 
T-cell development starts in the bone marrow from hematopoietic stem cells. Some of the 
stem cells give rise to the common lymphoid progenitors that differentiate into immature 
precursor T-cells. The immature precursors migrate to the thymus and proceed through thymic 
developmental stages.  While in the thymus, they differentiate into a double negative stage (DN). 
DN T-cells express neither CD4 nor the CD8 co-receptor. Based on surface expression of CD44 
and CD25, the DN T-cells are further classified into DN1, DN2, DN3 and DN4. The DN stage 
defines if the T-cell will express the αβ T-cell antigen receptor (TCR) or ƴδ TCR T cell lineage.  
In the case of a αβTCR, the DN T-cell differentiates into the double positive stage (DP) where it 
expresses both the CD4 and CD8 co-receptors. The DP T-cells go through positive and negative 
selection to eliminate potential self-reactive T-cells. Both selections result in the generation of 
single positive (SP) CD4+ and CD8+ T-cells. The SP cells then migrate to secondary lymphoid 
tissues and interact with APCs that present antigenic peptide; this interaction leads to activation 
and confers a defense against pathogens (Ellmeier, Haust, & Tschismarov, 2013; Sawada, 
Scarborough, Killeen, & Littman, 1994). During T-cell activation, the contact site between the T-
cells and APCs form a structural domain called the immunological synapse (IS) that is required 
for an effective T-cell activation and effector functions. 
APCs (including macrophages, dendritic cells and B cells) surveille tissues looking for 
pathogens or dying cells. Loaded with antigenic peptides, they migrate from tissues to lymphoid 
organs and present the peptides to T-cells, specifically CD4+ T-cells.  APCs internalize antigens 
through phagocytosis and/or receptor-mediated endocytosis. APCs then process those antigens to 
small peptides that can be loaded into the MHC molecules. This process is called antigen 
processing. The next step is the loading of those antigenic peptides into either MHC class I or 
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MHC class II depending on the source of the antigen which come from either the extracellular or 
the cytosolic environment for MHC class II or MHC class I, respectively.  The peptides loaded 
into MHC class II, for example, are transported to the cell surface and will present peptides to 
CD4+ T-cells. On the other hand, T-cells also proceed through different steps and check points to 
be ready to elicit a specific response to the particular antigenic peptide recognized (Neefjes, 
Jongsma, Paul, & Bakke, 2011). 
Naïve cells (unstimulated T-cells) are primarily stimulated by dendritic cells; this causes 
the T-cell to proliferate and differentiate into effector cells. Priming of naïve cells is critical for 
initiating T-cell responses against the pathogen; however, re-stimulation of effector T-cells 
through a second exposure to the same antigen causes a faster and more robust response against 
the pathogen. T-cell activation involves more than antigen recognition by antigen-specific TCRs 
and co-receptors; requiring regulation by a variety of molecular interactions with costimulatory 
and co-inhibitory molecules, cytokine receptors, adhesion molecules, and intracellular signaling 
cascades. 
4.2 T cell Activation and the Immunological Synapse (IS) 
 The TCR/CD3 complex is comprised of a TCR αβ heterodimer that is required and 
responsible for antigen recognition, and the non-polymorphic CD3 proteins that are responsible 
for initiating the intracellular signaling cascade. The CD3 protein is made of the heterodimers 
γδ and γε and the homodimer ζ-ζ (Portoles & Rojo, 2009; Shores et al., 1994; Smith-Garvin, 
Koretzky, & Jordan, 2009; Yuseff, Lankar, & Lennon-Dumenil, 2009). After ligand recognition, 
Lck (a Src family tyrosine kinase) becomes activated and phosphorylates immunoreceptor 
tyrosine-activation motifs (TAMs) within the cytoplasmic tail of the CD3 complex. This leads to 
calcium signaling and recruitment of other tyrosine kinases such as Zap-70, that bind to the 
phosphorylated ITAMs.  Zap-70 in turn acts as a scaffolding protein and recruits signaling 
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adaptors and effector molecules such as LAT, SLP-76, Grb2/Gads, and phospholipase C-y 
(PLCY). Zap-70 also activates other signaling molecules such as protein kinase C-Ɵ (PKCƟ), 
inducing cytokine production and controlling the activation of genes involved in T-cell survival 
and effector functions (Hashimoto-Tane et al., 2010; Yuseff et al., 2009). T-cell activation in the 
absence of co-stimulatory molecules causes the T-cells to become anergic (a non-responsive 
state) which leads to failure of T-cells to respond to further re-stimulations. Interaction of co-
stimulatory molecules such as CD28 with their ligands CD80 and CD86 provides additional 
signaling required for avoidance of anergy and for productive T-cell activation (Smith-Garvin et 
al., 2009). 
The IS represents the site of contact between T-cells and APCs or target cells (e.g., tumor 
cells). The IS is initiated early during T-cell activation and results in the accumulation of TCRs in 
apposition with peptide-MHC on the APC. Signaling begins at the periphery of the IS with the 
formation of microclusters that typically contain phosphorylated TCRs, associated signaling 
molecules (e.g. Zap70, SLP-76, etc.), and co-stimulatory molecules (e.g. CD28) (Hashimoto-
Tane et al., 2010) (Fig 1.6). These microclusters are transported to the center of the IS and form 
the central supra-molecular activation complex (cSMAC) (Fig 1.6).  Other key signaling proteins 
that localize to the cSMAC include Lck and LAT. The cSMAC is surrounded by an accumulation 
of cell adhesion molecules which pair with counter-receptors on APC, such as LFA1-ICAM1, 
forming a sealing zone called peripheral SMAC (pSMAC) (Griffiths, Tsun, & Stinchcombe, 
2010; Hashimoto-Tane et al., 2010; Huppa, Gleimer, Sumen, & Davis, 2003; Jo et al., 2010), Fig 
1.6). cSMAC is a site of both strong receptor activation and increased receptor degradation (Lee 





4.3. Endocytic Trafficking in T cells 
 Recent studies (Cemerski & Shaw, 2006; Finetti et al., 2009) have demonstrated that 
clustering of TCRs at the IS is a combination of lateral diffusion, cytoskeleton-derived 
movement, and polarized recycling. TCR/CD3 association starts at the ER and is completed at the 
Golgi. From the Golgi, TCR/CD3 is transported through endosomal vesicles to the cell surface.  
Several studies have shown that once the TCRs are on the surface, they undergo several rounds 
through the constitutive recycling pathway before being targeted for degradation (Das et al., 
2004; Finetti et al., 2009; Lee et al., 2003). The TCR/CD3 complexes go through the CME for 
internalization. Once internalized, they co-localize with TfR in the RE and in the IS, suggesting 
that internalized TCRs traffic through the recycling endosome back to the cell surface (Das et al., 
2004).  
It is well documented that T-cells become polarized during ligand activation, leading to 
the rearrangement of intracellular organelles such as the recycling endosomes, the Golgi, and the 
centrosome or MTOC directly underneath the IS (Yuseff et al., 2009).  The main purpose of 
MTOC/Golgi rearrangement is to direct secretion of Golgi-derived lymphokines from T-cells to 
the bound APC (Poo, Conrad, & Janeway, 1988), and to allow trafficking of newly synthesized 
TCRs from the Golgi to the surface. In addition, MTOC/Golgi rearrangement has also been 
required for the delivery of granules to the IS, hence controlling the killer function of cytotoxic T 
lymphocytes (CTLs) (Kloc, Kubiak, Li, & Ghobrial, 2014; Stinchcombe, Majorovits, Bossi, 
Fuller, & Griffiths, 2006).  Polarization of recycling endosomes is important for effective 
accumulation of TCRs at the IS. Studies have shown that constitutive internalization and 
recycling of TCRs are necessary for their accumulation at the IS (Das et al., 2004; Yuseff et al., 
2009). In some studies, internalization was seen as early as 6 min after T-cell-APC contact and up 


















Figure 1.6: Later Stages of the IS in T-cells: Vesicle Trafficking and Changes in 
Polarization and Membrane Morphology Determines Effector Functions. Membrane 
rearrangement leads to the formation of the cSMAC where immune-engaged receptors are 
clustered and the pSMAC that contains adhesion molecules forms a seal that keeps the T-cell and 
the APCs in contact during activation. [(Yuseff et al., 2009) with permission from the publisher] 
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T-cell activation leads to phosphorylation of the ITAM in the cytoplasmic tail of CD3 
proteins. Stimulation by a strong agonist triggers TCR internalization and degradation from the 
cSMAC, which leads to the down-modulation of the TCR signaling (Lee et al., 2003). 
Importantly, signal attenuation can also be caused by the function of co-inhibitory molecules such 
as CTLA-4, which competes with CD28 for binding to CD80 (or B7-1) and CD86 (B7-2) and 
disrupts tyrosine phosphorylation events through recruitment of intracellular SH-2 phosphatase 
(Huppa et al., 2003). However, while degradation through the lysosome is still considered one of 
the main ways of signal attenuation, some studies have shown that partially or slightly 
phosphorylated TCRs recycle back to the cell surface after internalization, while fully 
phosphorylated TCRs traffic to the lysosomes for degradation (Lee et al., 2003). These studies, 
together with other studies demonstrated that a small portion of surface TCRs are recycled back 
to the surface during activation, suggesting that the recycling endosome is a critical compartment 
controlling the traffic of recycling TCRs and newly synthesized TCRs to the surface. Therefore, 
the RE not only provides T-cells with TCRs that are ready for stimulation, but also at the same 
time sustains signaling by controlling the formation and maintenance of the IS.  
It has become clear and well accepted that the IS is a focal point of strong endocytic 
trafficking (Griffiths et al., 2010) (Fig 1.6). Most of the molecules that are required for the 
formation and maintenance of the IS such as TCRs (Huppa et al., 2003), CD28 (Cefai et al., 
1998), LFA-1 (Fabbri et al., 2005; Stanley, Tooze, & Hogg, 2012) on T cells and ICAM-I (Jo et 
al., 2010), MHC class I (Caplan et al., 2002) and MHC class II (Walseng et al., 2008) on APCs 
have been shown to undergo internalization and recycling back to the T-cell-APC interface 
during activation. Besides receptors, signaling molecules such as LAT and Lck also traffic to the 




Endocytic trafficking in T-cells has been well studied in the context of T-cell activation 
by either a ligand or antibodies (such as anti-CD3/CD28), but process of endocytic trafficking in 
unstimulated (naïve or resting) cells has received little focus. A study showed that activation of 
PKC induces internalization of TCR with subsequent sorting to a non-degradative compartment 
from which the TCR recycles back to the cell surface in a functional state (Dietrich et al., 1998). 
They also demonstrated that PKC-mediated internalization requires the phosphorylation of CD3ƴ 
S126.  The same group showed that de-phosphorylation of CD3ƴ following PKC-mediated 
internalization was required for TCR recycling and it was dependent neither on microtubules and 
actin polymerization nor on CD45 or Src kinases. Their study was among the first to suggest that 
PKC-dependent and ligand-dependent TCR sorting are two different pathways of receptor 
sorting. Their data also suggested that PKC-mediated TCR sorting via the RE is mainly used in 
unstimulated T-cells (before ligand binding), which are known to constitutively internalize and 
recycle their receptor with very little degradation as opposed to activated T-cells.  During ligand 
binding, both the PKC and tyrosine kinases are activated, but leads towards lysosomal sorting of 
TCR; therefore, suggesting that ligand-dependent sorting is more dominant than PKC-dependent 
sorting during activation (Dietrich et al., 1998). 
4.4. Similarities Between IS and other Synapses 
The IS exhibits various similarities with the neuronal synapse, and neuromuscular 
Junction (Boulanger, Huh, & Shatz, 2001; Dustin & Colman, 2002; Tarakanov & Goncharova, 
2009), both shown to be regulated by EHDs. EHD proteins were found to localize to and regulate 
neural synapses (Ioannou & Marat, 2012) and were implicated in various steps of endosomal 
trafficking in neuronal synapses (Ioannou & Marat, 2012; Lasiecka, Yap, Caplan, & Winckler, 
2010; Valdez et al., 2005; Yap et al., 2010). EHD1, in particular, was found to negatively regulate 
exocytosis in the vesicle release site by affecting the binding of the SNARE complex protein, 
SNAP-25 to snapin, preventing the association of synaptotagmin-1 to the SNARE complex (Wei 
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et al., 2010). SNAP-25 is also a t-SNARE expressed in T cells as SNAP-23 and shown to cluster 
at the IS (Das et al., 2004). Another study showed that the lamprey I-EHD (conserved EHD1/3 
orthologue) was found to be enriched at the synaptic release site and regulated the 
clathrin/dynamin-dependent synaptic vesicle budding and dynamin function (Jakobsson et al., 
2011). Collaborative studies between our laboratory and the Hoffman group at George 
Washington University demonstrated that endogenous EHD1 localizes at the neuromuscular 
junction in vivo (Mate et al., 2012). The fact that the EHDs play important roles in other synapses 
that have shown similarities with the IS suggest that they could also regulate the IS.  
Several studies have suggested a link between the process of ciliogenesis and IS 
formation (Griffiths et al., 2010). Our lab has found that the embryonic lethality observed in 
EHD1 null mice is associated with open neural tubes, loss of primary cilia on neuroepithelial 
cells, and defected ciliary SHH signaling due to a dysregulated transport of smoothened, a SHH 
receptor shown to be regulated by EHD1 (Bhattacharyya et al., 2016). Importantly, SHH 
signaling has been shown to control T-cell killing at the IS (de la Roche et al., 2013). In vitro 
studies of EHD1-null MEFs confirmed the role of EHD1 in primary ciliogenesis (Bhattacharyya 
et al., 2016). In addition, although hematopoietic cells lack primary cilia, an essential 
intraflagellar transport (IFT) component, IFT20, was found to be expressed by T-cells and is 
required for the recycling of the TCR/CD3 complex and other receptors that traffic to the IS back 
to the surface (Finetti et al., 2009; Finetti et al., 2014). Furthermore, knockdown of IFT20 
resulted in impaired recruitment and signaling at the IS. 
4.5 Potential Role of EHD Protein Family in T cell Function and in the IS 
EHD proteins regulate the recycling of a number of receptors that traffic through the 
clathrin-dependent and clathrin-independent pathway, including TfR, MHC class I, MHC class II, 
etc. (Caplan et al., 2002; Lin et al., 2001; Naslavsky & Caplan, 2011; Walseng et al., 2008).  
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Furthermore, uncoordinated 119 protein (unc119) which regulate the activation of Rab11, 
controls the exit of Lck, (a Src kinase that phosphorylates the ITAM of the TCR-CD3 complex 
and is recruited to the IS) from Rab11 endosomes to the plasma membrane (Gorska, Liang, 
Karim, & Alam, 2009), while the function of Rab11 is regulated by EHD proteins (George et al., 
2007; Naslavsky et al., 2006; Naslavsky & Caplan, 2011). Another study showed that the 
recycling of LFA-1 is dependent on the traffic of ICAM-1 to the IS (Jo et al., 2010). Furthermore, 
the same group demonstrated that ICAM-1 co-localized with MHC class II in intracellular 
endosomes and at the APC side of the IS during ligand stimulation (Jo et al., 2010). These results 
suggested that ICAM-1 uses the same traffic pathway as MHC class II, which has been shown to 
be regulated by EHD1 (Walseng et al., 2008). These data suggest the possibility that EHD1 could 
be responsible for the transport of both MHC class II and ICAM-1 to the IS on APCs during 
ligand stimulation. 
 Based on the importance of the endocytic traffic in T-cell function and IS formation and 
maintenance, we wanted to investigate the role of the EHD proteins in both T-cell function and in 
the IS. Given the importance of the endocytic trafficking in T-cell function and in IS during 
activation and the role of the EHD proteins in the neuronal synapse, in the neuromuscular 
junction, and in ciliogenesis, we  hypothesized that EHD protein will regulate the endocytic 
recycling of receptors and the stability of IS/APC contact formation/maintenance in unstimulated 


























2.5. Materials and Methods for Chapter 3 
5.1 Reagents & Antibodies 
Reagents: BSA (cat. # A7906-100G), paraformaldehyde (cat. # 158127-500G), Triton X-100 
(cat. # 93418), EGTA (cat # E8145-50G), sodium orthovanadate (Na3VO4, cat # S6508-50G), 
sodium deoxycholate (cat # D6750-100G), 4-hydroxtamoxifen (cat. # T176-10MG), and 
Brefeldin A (BFA, cat. # B7651) were from Sigma-Aldrich (St. Louis, MO). Propidium iodide 
staining solution (cat. # 00-6990-42) was from eBiosciences. 3H-thymidine (cat. # 2407001, 2.0 
Ci/mmol) was from MP Biomedical. Bafilomycin A1 (cat. # BML-CM110-0100)) was from Enzo 
Life Sciences. MOG peptide (amino acids 35-55) (cat. # BP001328-PRO-371) was from Syd 
Labs.  OVA peptide (amino acid 323-336) (sequence: ISQAVHAAHAEINE) was synthesized by 
Tufts University Core facility (Medford, MA, 02155).  CFA (cat. # 231131) and heat-inactivated 
Mycobacterium tuberculosis were from DIFCO Laboratories. Sodium fluoride (NaF, cat # S299-
500), sodium chloride (NaCl, cat # S271-10), and Tris (cat BP152-5) were from Fisher 
Chemicals. Pertussis toxin was from ENZO Life Sciences. ECL development reagent (cat. # 
32106), BSA for bicinchoninic acid assay (cat # 23209), and PMSF (cat # 36978) were from 
Thermo-Scientific. CFSE (cat. # C34554), CellTrace Violet stain (cat # C34557), RPMI-1640 
(cat. # SH30027.02), Penicillin/streptomycin (cat. # 15140-122) and FBS (cat. # 10427-028; lot # 
1662765A120-01) were from Life Technologies. Live/dead fixable blue dead cell stain kit was 
from Molecular Probes. IL-2 ELISA kit (cat. # M2000) was from R&D Systems, Inc.   
Antibodies: Anti-CD28 (cat. # 122007) and anti-LFA-1(cat. # 141011) was from Biolegend. 
Anti-CD3Ɛ (referred to as anti-CD3) (cat. # 553064, and 553057), anti-CD25 (cat. # 558642), 
anti-CD4 (cat. # 553051, and cat # 553047), anti-CD8α (cat. #560469), anti-CD28 (cat. # 
553294) and anti-CD44 (cat. # 553135) was from BD Bioscience. Anti-B220 (cat. # 25-0452-81), 
and anti-CD3Ɛ (referred to as anti-CD3) (cat. # 56-0032-80) were from eBioscience. Anti-HSC70 
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(cat. #sc-7298) and anti-LAMP1 1D4B (cat. # sc-19992) were from Santa Cruz Biotechnology. 
Anti-EHD1 (cat. # ab109311) was from Abcam. Anti-β-Actin (cat. # A5316) was from Sigma-
Aldrich. APC-conjugated anti-Annexin V (cat. # 17-8007-72) was from eBiosciences. Polyclonal 
rabbit antibodies recognizing EHD1 plus EHD4, EHD2 or EHD3 have been described previously 
(45). Secondary fluorochrome-conjugated antibodies were from Life Technologies. 
5.2 Mice Generation & Genotyping 
Whole-body knockout mice (Ehd1-null) derived from Ehd1flox/flox mice have been described 
previously (Rainey et al., 2010). Ehd1-null mice were maintained on mixed 129, B6 background. 
EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice in a predominantly C57BL/6 background were crossed with 
B6. Cg-Tg(Cd4-cre)1Cwi/BfluJ to generate Cd4-cre; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice. These 
mice were further crossed with C57BL/6-Tg (Tcra2D2, Tcrb2D2)1Kuch/J, 2D2 Tcr or MOG Tcr 
to generate Cd4-cre; 2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice. EHD1fl/fl; EHD3fl/fl; EHD4fl/fl 
mice in a predominantly C57BL/6 background were also crossed with tamoxifen-inducible 
CreERT2-expressing mice from Jackson Laboratories (Gt(ROSA)26Sortm1(cre/ERT2) Tyj; strain 
008463) to generate CreERT2; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice. These mice were further crossed 
with C57BL/6-Tg (Tcra2D2, Tcrb2D2)1Kuch/J, 2D2 Tcr or MOG Tcr) to generate CreERT2; 
2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice. Genotypes were confirmed by subjecting tail clip 
DNA to PCR analysis using the KAPA mouse genotyping kit (KAPA Biosystems). Mice were 
treated humanely according to the National Institutes of Health (NIH) and University of Nebraska 
Medical Center guidelines. Animal studies were pre-approved by the Institutional Animal Care 






Table 2.5.3. Primers Used for Tail PCR Genotyping (include modification codes if applicable) 
Oligo Names                  Sequences 5’ to 3’ 
Ehd1-1                            (AAGTCAGAAGACAACTTTCTGGAGTTCCCT) 
Ehd1-2                            (TCCAGGGCCCACATGGTAGAAGGAGAGAGT) 
Ehd1-3                            (GCTCCGGTCTTGGACTTCACCAGCATTTAG)  
Ehd3-212                        (CAACAAGAGTGTCAGGAAACCTGAACTAAG) 
Ehd3-213                        (CTGGGAAACTGCAGAACATCAGGGAACAGC) 
Ehd3-215                        (ATGAGGGACTCAAGGGGCAAGTCCTGGAGG)  
Ehd4-28                          (ACGCGTCGACACTAGCCCTTTGCATCTGTCAGTTA)  
Ehd4-32                          (ACGCGTCGACACCCAAACAAAGAGATGTTTAGTGC)  
Ehd4-33                          (GCCTGTGGCTGAAATATCATTAGT) 
Ehd4-35                          (ATTTGCGGCCGCGTCATTTGCAGGTGTCTAGTGAGTT)  
Ehd4-90                          (GGGTTATTGAATATGATCGGAATTGGGCTGCAGG) 
CreF                                (GCGGTCTGGCAGTAAAAACTATC) 








5.4 Western blotting 
Lymphoid tissues or isolated cells were lysed in ice-cold Triton X-100 lysis buffer (0.5% Triton 
X-100, 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM PMSF, 10 mM NaF, 1 mM VO4) or with 
RIPA lysis buffer (same as Triton X-100 lysis buffer with an increase of Triton X-100 to 1% and 
an addition of 5 mM EDTA, 1 mM EGTA, 1% SDS, and 0.5% sodium deoxycholate). Lysates 
were vortexed, centrifuged at 13,000 rpm for 30 minutes at 4o C either immediately or after 
overnight rocking in the cold room, and supernatants were collected. Protein lysates were 
quantified using the bicinchoninic acid (BCA) assay.  40 μg aliquots of lysate protein per sample 
were resolved by SDS/PAGE and transferred to PVDF membranes (from Immobilon-P, cat # 
IPVH00010). In certain experiments, lysates from equal numbers of cells were resolved by 
SDS/PAGE. The membranes were blocked in TBS/5% BSA, incubated with the appropriate 
primary antibodies diluted in TBS-0.1% Tween 20 for 1 hr, washed in TBS-0.1% Tween (3x for 
5 minutes each) followed by a 45-min incubation with HRP-conjugated secondary antibody in the 
same buffer. The membrane was then washed in TBS-0.1% Tween (3x for 5 minutes each) and 
ECL-based detection was performed.  
 5.5 CD4+T-cell isolation 
To isolate primary CD4+ T-cells, a negative selection protocol was performed as described 
(Kamala, 2008) using magnetic beads (Invitrogen Biotin binder kit cat. # 11533D) and 
biotinylated antibodies (Biolegend), and purity was established to be 91-95% based on flow 
cytometry. 
5.6 Fluorescence Activated Cell Sorting (FACS) 
T-cells were incubated on ice in the dark for 15 to 30 min (depending on the experiment) with 
appropriate conjugated antibodies at the manufacturer’s recommended dilution in FACS buffer 
(0.1% BSA in PBS). Cells were pelleted, washed twice, and suspended in 400 µl of cold FACS 
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buffer. In other cases, cells were fixed with 4% cold PFA for 15 min at room temperature after 
staining; then washed and suspended in 400 µl of cold FACS buffer. Cells were protected from 
light until analyses using either the LSR II Green or LSR II cytometer (BD Bioscience). FACS 
data were analyzed using DIVA (BD FACSDIVA TM Software), FlowJo (FLOWJO, LLC Data 
Analysis Software, Ashland, OR) and ModFit LT software (Verity Software House, Topsham, 
ME). 
5.7 CFSE and CellTrace VioleT-cell proliferation dye dilution assay  
Spleen cells (5x106cells/ml) from CD4-Cre; 2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice and 
control (2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl) mice were stained with CFSE or CellTrace Violet 
according to the manufacturer’s instructions. Cells were treated with 50 µg/ml of MOG35-55 
peptide for 72 hrs. On the indicated day, cells were stained with FITC-CD4 before analysis. 
Dilution of CFSE or CellTrace Violet fluorescence as an indicator of cell division was assessed 
via FACS analysis. Data were analyzed using FlowJo and ModFit LT software. ModFit LT 
software was also used to determine the Proliferation Index (PI). In some instances, the cells were 
not stained with the proliferation dye, but were stained with anti- AnnexinV and Propidium 
Iodide staining solution after 72 hrs of stimulation and analyzed by FACS for cell death analysis.  
5.8 3H-thymidine incorporation assay and T-cell expansion 
Spleen cells (5x105 cells/well) from CD4-Cre; 2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl or control 
(2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl) mice were seeded in 96-well U-bottom plates in 100 µl 
medium in the presence of varying concentrations of MOG35-55 peptide for 72 hrs.  Cells were 
pulsed with 1 µCi of 3H-thymidine per well for the last 6 hrs of incubation, harvested onto filter 
disks and the radioactivity (counts per minute) counted using a scintillation counter (Packard). 
For T-cell expansion, spleen cells or LN cells from CD4-Cre; 2D2Tcr; EHD1fl/fl; EHD3fl/fl; 
EHD4fl/fl mice and control (2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl) mice were stimulated with 10-
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20 µg/ml of MOG 35-55 peptide and T-cells were expanded in the presence of 30 U/ml IL-2 for 7-8 
more days (in fresh IL-2-containing media changed every two days after three days of 
stimulation).  
5.9 In vitro deletion of EHD proteins (EHD1, 3 and 4) 
Spleen cells or LN cells from EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; CreERT2; 2D2Tcr mice were pre-
stimulated with either the MOG peptide or with anti-CD3 and anti-CD28 for three to four days in 
the presence (+) or absence (-) of 4-hydroxytamoxifen (4-OHT) (200 nM-300 nM) for deletion of 
EHD 1, 3 and 4. Cells were washed in PBS, stained with CFSE, and were re-stimulated for 
proliferation as previously described.  
5.10 ELISA 
Isolated spleen cells (5x105 cells/well) were cultured in 96-well U-bottom plates in the presence 
of 10 µg/ml of MOG35-55 peptide at 37oC for indicated time points. IL-2 secretion was measured 
in culture supernatants using an ELISA kit according to the manufacturer’s instructions. 
5.11 Cell surface TCR internalization assay  
Internalization of cell surface pool of TCR-CD3 was assessed as previously described (Carrasco, 
Navarro, & Toribio, 2003; H. Liu, Rhodes, Wiest, & Vignali, 2000) with modifications. Briefly, 
freshly isolated LN cells at 5x106 cells/ml in 96-well U-bottom plates (in triplicates) were 
incubated in the presence of 10 g/ml BFA at 37oC for the indicated times to allow the surface 
TCR to internalize in the absence of newly synthesized TCR transport to the cell surface. At each 
time point, cells were transferred into ice and subsequently stained with PE-conjugated anti-CD3 
followed by FACS analysis to quantify the surface TCR levels remaining at each time point. The 
extent of the TCR remaining at the cell surface was calculated by expressing the median 
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fluorescent intensity (MFI) of PE-anti-CD3 staining at each time point relative to time 0, which 
was set as 100%. 
5.12 Analysis of TCR recycling 
 The recycling of pre-existing intracellular pools of TCR-CD3 was carried out by adapting a 
previously described protocol (Dietrich et al., 2002). Briefly, the accessibility of the cell surface 
CD3 on freshly isolated LN cells (at 5x106 cells/ml in 96-well U-bottom plates in triplicates) was 
blocked by staining with a predetermined saturating concentration of unconjugated anti-CD3 at 
4oC for 30 min. The cells were extensively washed and incubated at 37oC. At the indicated times, 
the cells were transferred to 4oC and stained with a PE-conjugated version of the same anti-CD3 
antibody that was used to block the staining of the initial cell surface cohort of CD3. The MFI of 
PE-anti-CD3 cell surface FACS staining was used as a measure of the recycling of intracellular 
TCR-CD3. Recycling of cell surface TCR-CD3 pool following internalization was assayed by a 
modified protocol (Osborne, Piotrowski, Dick, Zhang, & Billadeau, 2015; Sullivan & Coscoy, 
2008). Freshly isolated LN cells were first stained with PE-conjugated anti-CD3 for 30 min on 
ice. After extensive washes, the cells were incubated at 37oC for 30 min (in complete RPMI) to 
allow the antibody-labelled TCR-CD3 to undergo internalization. The cells were then subjected 
to an acid wash to strip any remaining antibody bound to CD3 on T-cell surface. The cells were 
washed in cold FACS buffer and re-suspended in complete RPMI followed by incubation at 37oC 
for the indicated times to allow recycling of the labelled internalized pool of TCR-CD3 back to 
the cell surface. The cells were spun down, acid washed, and re-suspended in FACS buffer for 
FACS analysis to determine the remaining intracellular fraction of the internalized TCR-CD3. 
The percentage of TCR-CD3 recycling was calculated from the equation ((T0-Tx)/T0) x 100, where 
T0 is the MFI of cells incubated for 0 min before the second acid wash, while Tx is the MFI of 
cells subjected to a second acid wash after incubation for the indicated times. 
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5.13 Confocal Microscopy 
Lymph node T-cells were expanded as described under T-cell expansion. A total of 5 x106 
expanded T-cells in complete RPMI medium were plated onto Poly-L-lysine-coated coverslips 
placed in 24-well plates and allowed to attach at 37oC for 10 min. Cells on coverslips were fixed 
in 4% ice-cold PFA for 20 min and then incubated with 0.1M glycine (in PBB) for 3 min at room 
temperature. After washing, the cells were incubated with the blocking plus permeabilization 
buffer (2% BSA +0.1% Triton in PBS) for 30 min at room temperature. Cells were stained with 
anti-Lamp-1 and anti-CD3 primary antibodies overnight a 4oC. After three washes, the cells were 
stained with secondary anti-rat (for Lamp-1) and anti-Armenian hamster antibodies for 45 min at 
room temperature. After washes, the cells were mounted with VECTASHIELD Hard Set 
mounting medium with DAPI (Vector laboratories, Cat # H-1500). Images were acquired at room 
temperature using a ZEISS ELYRA S.1 and superresolution structured illumination (SR-SIM). 
The sCMOS camera mounted on side port was used. Objective lenses: Plan-APOCHROMAT 
63x/1.40 Oil DIC. For resolution: lateral resolution (XY): 120 nm, axial resolution (Z): 300 nm 
(typical experimental FWHM values with objective lens Plan-APOCHROMAT 63x/1.40 Oil 
DIC, subresolution beads of 40 nm diameter and excitation at 488 nm). Merged fluorescence 
pictures were generated and analyzed using ZEN ®2012 software from Carl Zeiss. 
5.14 Induction and monitoring of Experimental Autoimmune Encephalomyelitis (EAE) 













) mice were subcutaneously immunized in the flank with 200 µg of 
MOG35-55 peptide emulsified (1:1) in complete Freund’s adjuvant (CFA) containing 0.5 mg heat-
killed Mycobacterium tuberculosis H37RA in a total of 200 µl emulsion per mouse, together with 
an intraperitoneal injection of pertussis toxin (200 ng/mouse) in 200 µl PBS followed by a second 
dose of pertussis toxin two days later. Mice were monitored daily and scored for clinical signs of 
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EAE on a scale of 0-5 whereby 0 = no disease; 1 = decreased tail tone; 2 = hind limb weakness or 
partial paralysis; 3 = complete hind limb paralysis; 4 = front and hind limb paralysis; and 5 = 
moribund state or dead (Bettelli et al., 2003). Composite scores of each cohort were used to 
determine statistical significance. 
5.15 Statistics 
An unpaired student’s t test was used to calculate the p-values. Data are presented as 



































Understanding of the mechanisms that underlie proper T-cell function is of great interest 
in basic immunology and immunopathology. T-cell activation requires recognition of an antigenic 
peptide bound to MHC proteins on antigen presenting cells (APC) by the T-cell antigen receptor 
(TCR) and downstream signaling mediated by cytoplasmic regions of the TCR-CD3 complex. 
Effective generation of an immune response requires concurrent engagement of and signaling 
through co-stimulatory proteins (e.g., CD28) on T cells by their cognate ligands on the APC 
surface (Huppa et al., 2003). Therefore, the mechanisms that ensure optimal levels of the TCR 
and accessory receptors on the T-cell surface prior to antigen stimulation are fundamentally 
critical to generating an effective immune response. However, mechanisms that regulate the 
surface pool of TCR and its accessory receptors have been primarily investigated in the context of 
T-cell activation. During T-cell activation, TCR signaling elicited by the APC-presented antigen, 
together with co-stimulatory signals, leads to spatial reorganization of the TCR and accessory 
receptors, such as CD28 and lymphocyte function-associated 1 (LFA-1), to form an area of 
intimate contact with APCs, the immunological synapse (IS) (Hashimoto-Tane et al., 2010; Jo et 
al., 2010). The endocytic pathways supply the IS with newly synthesized and recycled receptors 
to replenish those that are targeted to the lysosome for degradation (Das et al., 2004; Lee et al., 
2003; Valitutti, Muller, Salio, & Lanzavecchia, 1997) . 
Cells use clathrin-dependent as well as clathrin-independent pathways to internalize 
surface receptors into early (EE)/sorting endosome compartments, from where they traffic to late 
endosome/multi-vesicular bodies and lysosomes for degradation, or recycle back to the cell 
surface.  To go back to the cell surface, receptors either through a Rab4+ fast recycling endosome 
(RE) (directly to the plasma membrane) or through a slow recycling route via the Rab11+ RE 
(Gould & Lippincott-Schwartz, 2009; Naslavsky & Caplan, 2011). This sorting process is known 
to be regulated by Rab family of small GTPases and their interacting partners (Walseng et al., 
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2008). T-cell receptors such as TCR-CD3 (Huppa et al., 2003), CD28 (Cefai et al., 1998) and 
LFA-1 (Fabbri et al., 2005; Stanley et al., 2012) are known to be internalized and recycled to the 
IS during T-cell activation. Internalized TCR-CD3 traverses the Rab5+ EE, followed by transport 
through Rab4+ and Rab11+ endosomes, indicating the involvement of both fast and slow recycling 
pathways (Kumar, Kremer, Dominguez, Tadi, & Hedin, 2011; H. Liu et al., 2000). Naïve and 
resting T-cells constitutively internalize and recycle their surface receptors and the balance of 
these processes dictates their pre-stimulation surface levels and hence the levels of T-cell 
activation (H. Liu et al., 2000). Yet, the mechanisms of constitutive basal traffic of TCR-CD3 are 
not fully understood. 
Recently, a new family of endocytic regulators, the EPS15 Homology Domain-containing 
proteins (EHD1-4), has been identified. These proteins exhibit a conserved domain architecture 
with helical regions near the N-terminus and the middle of the protein surrounding an ATP-
binding G-domain that can hydrolyze ATP slowly, and a C-terminal EH domain that binds to 
proteins with asparagine-proline-phenylalanine (NPF)-containing or related tripeptide motifs as a 
major mechanism of protein-protein interactions (Mintz et al., 1999; Pohl et al., 2000). Structural 
studies of EHD2 reveal that the helical regions form a curved membrane lipid-binding interface, 
and that the ATPase domain folds similar to the GTPase domain of dynamin and mediates the 
formation of stable dimers (Daumke et al., 2007). Other structural findings support a model that 
dimeric EHDs organize into oligomeric rings around curved membrane structures and function in 
membrane tubulation and vesiculation (Blume, Halbach, Behrendt, Paulsson, & Plomann, 2007; 
Daumke et al., 2007; Ioannou & Marat, 2012; Jakobsson et al., 2011; Shah et al., 2014). 
Consistent with these biochemical observations, cell biological studies have shown that EHD 
proteins regulate recycling of several surface receptors that traffic through clathrin-dependent or 
clathrin-independent pathways, including transferrin receptor, MHC class I, β1 integrin, AMPA 
receptors, insulin-like growth factor 1 receptor (IGF1R), insulin-responsive glucose transporter 4 
(GLUT4), and others (Caplan et al., 2002; George et al., 2007; Grant et al., 2001; Guilherme et 
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al., 2004; Jovic et al., 2007; Lasiecka et al., 2010; Lin et al., 2001; Naslavsky & Caplan, 2011; 
Rapaport et al., 2006). However, the physiological relevance of the many in vitro assigned roles 
of EHD proteins remains to be defined. 
We used gene targeting in mice to reveal the in vivo functional roles of EHD proteins and 
cell surface receptors whose traffic is regulated by EHDs (Curran et al., 2014; Cypher et al., 
2016; Demonbreun et al., 2015; Doherty et al., 2008; Gudmundsson et al., 2010; Posey et al., 
2011; Posey et al., 2014). For example, EHD1 KO mice exhibit strain-dependent phenotypes 
varying degrees of  embryonic lethality, male infertility, ocular developmental defects, and neural 
tube closure defects due to impairment of ciliogenesis and SHH signaling (Arya et al., 2015; 
Bhattacharyya et al., 2016).  
To date, any roles of EHD-family proteins in TCR traffic or T-cell function are unknown. 
Given their importance in the regulation of a variety of other cell surface receptors and the 
consequences of deleting their genes, singly or in combination, on organ/cell function in vivo, we 
hypothesized that EHD proteins could play an important functional role in T cells by regulating 
receptor traffic. Consistent with such a hypothesis, EHD proteins have been shown to interact 
with Rab effectors, such as Rabenosyn-5, a dual Rab4 and Rab5 effector in the early endosome 
(Naslavsky, Boehm, Backlund, & Caplan, 2004), and Rab11 effector, Rab11-FP2, which 
regulates the exit of vesicles from the recycling endosome back to the plasma membrane 
(Naslavsky et al., 2006). Moreover, EHD proteins (EHD1, EHD3, and EHD4) were shown to 
interact with SNARE complex proteins such as SNAP-25, SNAP29 (Lu et al., 2015; Rotem-
Yehudar, Galperin, & Horowitz, 2001), Syndapin I and II (Braun et al., 2005; Giridharan et al., 
2013; Naslavsky & Caplan, 2011), and other proteins in non-T-cell systems. EHD proteins have 
been shown to localize in endosomes positive for Rab5, Rab4, Rab8, Rab11 or Rab35 (Caplan et 
al., 2002; Lasiecka et al., 2010; Sharma et al., 2008; Walseng et al., 2008), compartments that ae 
implicated in TCR traffic (Finetti et al., 2014; Finetti et al., 2015; Patino-Lopez et al., 2008). 
Thus, we posited that EHD proteins could play an important functional role in T cells. 
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 We found that EHD 1, 3 and 4 are expressed in lymphoid tissues and in purified CD4+ T 
cells. Accordingly, we generated myelin oligodendrocyte glycoprotein (MOG)-specific TCR 
transgene (2D2-TCR Tg)-bearing mice in which floxed EHD 1, 3 and 4 were deleted using a 
CD4-Cre transgene. In vitro, CD4+ T-cells of EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; Cd4-cre; 2D2Tcr 
mice (EHD1/3/4 knockout) exhibit reduced antigen-driven cell proliferation and IL-2 secretion. 
In vivo, these mice exhibit a reduced severity of experimental autoimmune encephalomyelitis 
(EAE) elicited by immunization with the MOG peptide. We show that surface levels of TCR, 
CD28, and LFA-1 are reduced and TCR recycling is impaired in CD4+ T cells of mice with a 
CD4-Cre-mediated EHD1/3/4 knockout. Therefore, our studies reveal a novel role of the EHD 
family of endocytic recycling proteins in the surface display of TCR in unstimulated T cells that 
contributes to their positive functional role in antigen-induced T-cell activation and 
immunopathology. 
3.7. Results: 
7.1 Multiple EHD Family Members are Expressed in Lymphoid Organs and Purified CD4+ 
T-cells. 
Our previous Western blotting studies of EHD protein expression in the mouse thymus 
and spleen (George et al., 2010; George et al., 2011; Rainey et al., 2010), which we extended here 
to lymph nodes (LN) (Fig. 1A), showed that multiple EHD family members are expressed, albeit 
unequally, in lymphoid organs. This suggested that multiple EHD family members are likely to 
be expressed in individual immune cell types, consistent with our recent findings that bone 
marrow-derived macrophages (BMDMs) express both EHD1 and EHD4 (Cypher et al., 2016). 
With the focus of this study on functional analyses in the context of CD4+ T-cells, our additional 
analyses showed that EHD 1, 3 and 4 are expressed in primary murine CD4+ T-cells (Fig. 1B) 
while EHD2 protein was undetectable to barely detectable. Analyses of mRNA expression 
databases (ImmGen and BioGPS) further support this expression pattern. Notably, western 
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blotting of purified LN T-cells at various time points of anti-CD3/CD28 stimulation showed that 
levels of EHD proteins vary as a function of CD4+ T-cell activation, with a time-dependent 
increase in EHD 1 and 4 levels and a reduction in EHD3 levels (Fig. 2). These findings suggested 
that EHD proteins may play important roles in T-cell function. 
Our previous knockout studies have revealed relatively unique as well as redundant 
functional roles of EHD proteins, with the knockout of EHD1 alone producing by far the most 
obvious developmental and adult organ functional aberrations, depending on the strain 
background (Arya et al., 2015; Bhattacharyya et al., 2016; Rainey et al., 2010; Rapaport et al., 
2006). We assessed lymphoid organs of EHD1-/- mice for any immune defects and we saw that 
globally, their lymphoid tissues maintained normal structural architecture compare to those from 
the Wt mice (Fig. 3A). Therefore, we assessed whether EHD1 deficiency had any impact on T-
cell activation. Notably, the initial analysis of EHD1-/- splenic T-cells did not reveal any 
detectable abnormality in anti-CD3/CD28 induced cell proliferation (Fig. 3B). These findings 
supported a redundant functional role of EHD proteins, at least in the context of T-cell 
proliferation. Consistent with this, an increase in EHD4 levels was noted in LN from EHD1-/- 
mice (Fig. 3C). In addition, we also noted an increase in the levels of both EHD1 and EHD4 in 
spleen and lymph nodes of EHD3-/- mice (Fig. 3D). Initial analysis of EHD4-/- T-cells shows that 
they proliferate less than CD4+ T cells from control mice (Fig. 3E, 3F). We also noted that the 
deletion of EHD4 in lymph node cells did not cause an increase in the level of EHD1 and 
EHD3.Given the likelihood of redundant EHD function, we used a combinatorial knockout 





7.2 CD4-Cre-Mediated Conditional Deletion of EHD1/3/4 in T-cells Leads to a Reduced 
Proportion of CD4+ T-cells in Secondary Lymphoid Tissues. 
Given the likelihood of redundant EHD function, we generated mice with a CD4-Cre-
depepndent, T-cell directed, conditional deletion of floxed Ehd1, Ehd3, and Ehd4 genes.  To 
examine the impact of EHD 1/3/4 deletions in T-cells in the context of antigen-specific responses, 
we also incorporated the MOG peptide-specific 2D2-Tcr transgene (Bettelli et al., 2003) into our 
conditional knockout model (referred to as CD4-Cre+ mice) (Fig. 4). Littermates without a CD4-
Cre transgene were used as controls (referred to as CD4-Cre- mice). Western blot analysis of 
CD4+ T-cells isolated from the 2D2-Tcr transgenic mice showed that the presence of the 
transgenic TCR by itself did not have any detectable impact on the levels of EHD proteins (Fig. 
5A). CD4-Cre+ mice were developmentally indistinguishable from CD4-Cre- mice and no gross 
phenotypic changes were seen in adult mice. We check the specificity of the transgenic receptor 
to the antigen and showed that they are specific to the MOG peptide (Fig. 5B, 5C, & 5D). Tail 
PCR and Western blot analysis confirmed the CD4-dependent deletion of EHD1/3/4 (Fig. 5E and 
Fig. 6A).  
Next, to examine whether EHD1/3/4 deletion impacted T-cell development, we isolated 
single cells from lymphoid organs of 4-week-old mice and analyzed these for changes in T-cell 
numbers using cell counting combined with FACS. We found that total numbers of thymocytes, 
splenocytes, and LN cells were comparable in mice from both groups (Fig. 6B). Similarly, 
comparable cell numbers were observed when spleens of older (6-8 weeks old) mice of the two 
genotypes were analyzed (Fig. 6C).  We carried out FACS analyses on the live/B220- T-cell 
population, and assessed the proportion of cells at various developmental stages based on staining 
with antibodies against CD4, CD8, CD25 and CD44 (Dashtsoodol, Watarai, Sakata, & Taniguchi, 
2008; G. Liu et al., 2014; Wang et al., 2009). Single positive thymocytes in 2D2-Tcr Tg mice are 
known to be skewed toward the CD4+ T-cell compartment; this is also seen in spleen and LN 
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(Bettelli et al., 2003) (Fig. 5F). CD4-Cre-mediated deletion of EHD 1/3/4 did not affect the 
relative percentages or total cell numbers within various thymic developmental stages when 
analyzed in 4-week-old mice (Fig. 6D and 6E).  
In contrast, CD4-Cre-mediated EHD1/3/4 deletion led to a decrease in the percentage of 
T-cells in the periphery. This phenotype was seen in both the spleen and LN (Fig. 6F, 6G). 
However, the absolute number of CD4+ T-cells in these organs did not differ significantly 
between CD4-Cre positive and control mice. In addition, an apparent increase in peripheral B cell 
numbers and their percentages were seen (Fig. 6F, 6G); the basis of this phenotype is unknown 
but is likely to reflect altered T-cell- B-cell interactions due to T-cell deficiency of EHD1/3/4. We 
also saw a decrease in the percentage of CD8+ T-cells in spleens of CD4-Cre positive mice, but 
this did not reflect an increase in CD8+ T-cell numbers in these same organs. From these results, 
we conclude that expression of EHD proteins is dispensable during thymic T-cell development, 
but may play a role in peripheral T-cell function. 
7.3 Expression of EHD Proteins is Required for Optimal Antigen-Induced T-cell Activation 
in vitro and for EAE in vivo. 
Incorporation of a MOG antigen-specific TC transgene in our EHD1/3/4 deletion models 
allowed analyses of CD4+ T-cell response to a specific antigen, both in vitro and in vivo, the latter 
in the context of the development of EAE. We asked whether the mature T-cells in these mice 
exhibit any functional deficits. Initial experiments, using spleen cells from the parental 2D2-TCR 
transgenic and control mice with MOG or ovalbumin peptides, established the optimal 
concentrations of MOG peptide to induce T-cell proliferation (not shown). Analysis of CD4+ T-
cells from spleen using the CellTrace Violet stain and 3H-thymidine incorporation showed a 
significant decrease in proliferation of T-cells from CD4-Cre+ mice compared to control CD4-
Cre- (Fig. 7A, 7B). Visualization of progressive cell divisions using ModFit LT software, showed 
that while CD4-Cre+ and CD4-Cre- CD4+ T-cells progress through a comparable number of 
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divisions, EHD1/3/4-null T-cells exhibit a significant underrepresentation at late divisions and an 
increased proportion of cells at earlier divisions (Fig. 7A). The EHD1/3/4-null T-cells also 
exhibited a significantly lower overall proliferation index (Fig. 7A), further supporting the 
conclusion that these cells proliferate slower than the control T-cells. To exclude the possibility 
that the apparent decrease in the number of EHD1/3/4-null T-cells at late stages of proliferation 
might be due to their apoptosis, we stimulated the CD4+ T-cells as previously described and 
stained these with PI and anti-Annexin V followed by FACS analysis. We observed no increase 
in the percentage of apoptotic cells in antigen-stimulated CD4+ T-cells isolated from CD4-Cre+ 
compared to CD4-Cre- (control) mice (Fig. 7C). Thus, the mature peripheral CD4+ T-cells of 
CD4-Cre- exhibit a marked defect in the specific antigen-induced cell proliferation in vitro. 
To assess whether the impact of EHD1/3/4 protein deficiency on CD4+ T-cell 
proliferation reflects their abnormal development or an actual importance in the events associated 
with T-cell activation, we used T-cells from 2D2-TCR Tg-bearing mice carrying a tamoxifen-
inducible ERT-Cre that allows in vitro deletion of EHD1/3/4.  EHD1/3/4 deletions in vitro led to 
a significant decrease in antigen-induced proliferation compared to their control T-cells (Fig. 7D, 
7E, 7F). These results support a T-cell intrinsic positive role of EHD proteins in sustaining 
antigen-driven T-cell responses in mature peripheral T-cells. 
 Among the cytokines that initiate antigen-activated T-cells into proliferation is the 
activation-induced secretion of IL-2 and the induced expression of the corresponding receptor on 
the T-cell surface (Boyman & Sprent, 2012; Malek, Yu, Scibelli, Lichtenheld, & Codias, 2001). 
Therefore, we assessed the impact of EHD1/3/4 deletions on IL-2 secretion. We observed a 
significantly lower level of antigen-induced IL-2 secretion by EHD1/3/4-null CD4+ T-cells (Fig. 
7G) with a difference detectable at the earliest time point (12 hrs) analyzed, making it unlikely 
that the reduction is due to a smaller pool of T-cells caused by reduced proliferation. The 
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significant reduction in IL-2 secretion is likely to represent one mechanism for the defective T-
cell proliferation upon deletion of EHD1/3/4.  
The impact of EHD1/3/4 deficiencies was not restricted to in vitro T-cell responses alone. 
Using immunization with the MOG35-55, we were able to test the impact of EHD1/3/4 deficiencies 
on the development of EAE in vivo. We immunized cohorts of control (CD4-Cre-) vs. 
experimental (CD4-Cre+) mice with MOG35-55 and assessed onset and severity of EAE over time. 
Interestingly, while no significant difference in the disease onset was seen, EHD1/3/4 –null group 
showed a decrease in the disease severity compared to control littermates (Fig. 7H). These results 
further support our conclusion that the expression of EHD proteins is important for full CD4+ T-
cell responses to antigen. Altogether, these in vitro and in vivo analyses established, for the first 
time, that EHD proteins play an important positive role in antigen-driven T-cell activation and 
immune response.  
7.4 EHD Proteins Regulate the Traffic of the TCR-CD3 Complex to the Cell Surface. 
At a cellular level, EHD proteins have been characterized as regulators of the endocytic 
traffic of cell surface receptors as mentioned in the introduction. Endocytic traffic of these 
receptors is key to their targeting to the immunological synapse (Andres et al., 2004; Cefai et al., 
1998; Fabbri et al., 2005; Huppa et al., 2003; H. Liu et al., 2000; Qureshi et al., 2012; Stanley et 
al., 2012; Valk, Rudd, & Schneider, 2008; von Essen et al., 2004). To assess whether EHD 
proteins may indeed regulate the traffic of TCR-CD3 or the accessory receptors, we first 
examined the cell surface levels of TCR-CD3, CD28, and LFA-1 by FACS analysis of 
unstimulated T cells. As assessed by comparing the MFI values, T-cells from CD4-Cre+ mice 
expressed significantly lower levels of TCR-CD3 on the cell surface compared to T-cells from 
control mice (Fig. 8A). These analyses also showed that in vitro activated CD4+ T-cells from 
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CD4-Cre+ mice express lower levels of TCR-CD3, CD28, CD25, CTLA-4 and LFA-1 compared 
to those from control mice (Fig. 8A). 
Since the TCR-CD3 complex is the primary determinant of antigen-specific T-cell 
activation and subsequent responses, we focused on the TCR for further analyses. We examined 
the kinetics of TCR-CD3 internalization and recycling in unstimulated CD4+ T-cells. Analysis of 
TCR-CD3 internalization using FACS showed that there was not significant difference in 
internalization of TCR in EHD1/3/4 -null T-cells compared to control T-cells (Fig. 8B). Next, we 
analyzed recycling to the cell surface of the pre-existing intracellular pool of TCR/CD3. For this 
purpose, anti-CD3Ɛ antibody recognition epitope on the pre-existing surface TCR-CD3 was 
blocked with an un-conjugated antibody and the appearance of intracellular TCR-CD3 on the cell 
surface at various time points was monitored by staining with a conjugated anti-CD3Ɛ. These 
analyses showed that EHD1/3/4 -null CD4+ T-cells exhibit a significantly reduced recycling of 
pre-existing intracellular TCR-CD3 to the cell surface at all time points analyzed compared to 
control T-cells (Fig. 8C). Next, we assessed the recycling of the pre-existing cell surface pool of 
TCR-CD3 by pre-labelling it with a PE-conjugated anti-CD3 and allowing it to internalize.  After 
acid wash (to strip any remaining antibody bound to TCR-CD3 on T-cell surface), the 
internalized PE-labeled TCR-CD3 was allowed to reappear at the cell surface and re-stripped to 
remove the labeled antibody. Even under these assay conditions, we observed a significant 
decrease in the recycling of TCR-CD3 in EHD1/3/4 -null CD4+ T-cells compared to control cells 
(Fig. 8D). Overall, these results show a key requirement for EHD 1, 3 and 4 in basal recycling of 





7.5 Deletion of EHD1, 3 and 4 Promotes the Lysosomal Degradation of TCR-CD3. 
 Given the impairment of the endocytic recycling together with the reduced steady-state 
surface TCR-CD3 levels in freshly isolated EHD1/3/4-null T cells (Fig. 8A, 8C, 8D), we 
considered the possibility that the pool of TCR-CD3 that is retained in intracellular compartments 
may be aberrantly targeted for lysosomal degradation. To address this, EHD1/3/4-null T cells 
(from CD4-Cre-mediated and 4OHT-induced ERT-Cre deletion) were examined by western 
blotting for total levels of CD3Ɛ. In both cases, we found that deletion of EHD proteins led to a 
significant decrease in the total levels of CD3Ɛ (Fig. 9A, 9B). Given our findings with the CSF-1 
receptor in macrophages (Cypher et al., 2016), we hypothesized that this reduction was likely due 
to lysosomal targeting and degradation. To test this hypothesis, we treated the EHD1/3/4-null T-
cells with or without bafilomycin-A1, an inhibitor of lysosomal degradation, for 4 h and analyzed 
the impact on total CD3Ɛ levels using western blotting and confocal (Fig. 10).  Western blotting 
of cells treated with Bafilomycin A1 for 4 h showed a recovery of the CD3Ɛ protein level in 
EHD1/3/4 -null T cells with levels in treated cells comparable to those in control cells (Fig. 10A, 
10B). We performed confocal imaging of control and EHD1/3/4 -null T cells incubated with or 
without bafilomycin-A1. Some co-localization was seen in Bafilomycin A1-treated control T 
cells (Fig. 10C, upper panel). Notably, significantly more lysosome-localized CD3Ɛ was seen in 
EHD1/3/4 -null cells treated with bafilomycin-A1 (Fig. 10C, lower panel and Fig 10D right). 
However, relatively low CD3Ɛ staining was co-localized with the lysosomal marker LAMP-1 in 
untreated cells (Fig. 10D left). These results support the conclusion that expression of EHD1/3/4 
is required for efficient transport of TCR-CD3 from endosomal compartments back to the cell 





3. 8.  Discussions 
Cellular studies have identified members of the EHD protein family as key new 
regulatory elements of endocytic trafficking of several cell surface receptors, but their 
physiological functions remain relatively unexplored and their roles in the immune system 
unknown. Here, we investigate the role of EHD proteins in the context of antigen-specific CD4+ 
T-cells in vitro and in vivo.  Our genetic studies, ablating genes encoding three members of the 
EHD protein family (EHD 1, 3 and 4) by CD4+ T-cells in the context of MOG transgenic TCR, 
demonstrate for the first time, an important, positive role of EHD proteins in antigen-specific T-
cell activation in vitro and an autoimmune response in vivo. Mechanistically, we show that EHD 
proteins are required for basal recycling of TCR-CD3 from intracellular endocytic pools to the 
cell surface, thereby determining the subsequent level of T-cell activation.  Combined with our 
recent study demonstrating a key positive role of EHD1 in the transport of newly synthesized 
CSF-1R from the Golgi to the cell surface of BMDMs (Cypher et al., 2016) and previous cell 
biological findings that EHD1 facilitates MHC class I recycling from the endocytic recycling 
compartment to the cell surface in a cell line system (Caplan et al., 2002), our results strongly 
support the likelihood that EHD proteins play critical and potentially diverse roles in the immune 
system. 
Analysis of thymic T-cell development did not reveal any significant alterations in total 
cellularity, T-cell subsets or relative proportions of T-cells at different stages in mice with a CD4-
Cre mediated deletion of EHD1/3/4, indicating that EHD proteins are largely dispensable for 
thymic development beyond the CD4/8 double-positive stage. Whether this might reflect any role 
of the remaining EHD family member, EHD2, remains a possibility that will require future 
studies. It is also possible that EHD proteins are important at earlier stages of thymic 
development and future use of other Cre elements active at these stages will be needed to address 
this possibility. Also, since our analyses, of which the primary purpose was not to probe thymic 
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development, were carried out in the context of a pre-rearranged TCR transgene, this could have 
masked a potential developmental role of EHD proteins in the context of a normally diverse TCR 
repertoire. 
In contrast to the relatively unperturbed thymic development, CD4-Cre-mediated 
EHD1/3/4 deletion led to a decrease in the percentage of T cells in the periphery. This phenotype 
was seen in secondary lymphoid tissues, including the lymph nodes and the spleen. These results 
suggested that EHD proteins may play a more important role in mature peripheral T cells. The 
precise basis for this phenotype remains unclear but lower functional responses to TCR 
engagement, as seen in ex vivo analyses (discussed below), could play a role since TCR signals 
are important in peripheral T-cell maintenance (Cantrell, 1996; Daniels & Teixeiro, 2015; Surh & 
Sprent, 2008). In addition, an apparent increase in the peripheral B cell numbers and their 
percentages was seen; the basis of this phenotype is unknown but is likely to reflect altered T-
cell- B-cell interactions due to T-cell deficiency of EHD1/3/4. 
The in vitro analyses of T cells from the CD4-Cre deletion model demonstrated 
significantly defective antigen-elicited CD4+ T-cell proliferation and IL-2 cytokine secretion 
responses upon EHD1/3/4 deletion.  Similar results were observed using CD4+ T cells derived 
from an alternate model where in vitro deletion of floxed EHD1, 3 and 4 genes was induced with 
4-OHT to bypass any in vivo developmental abnormalities. These results support a T-cell intrinsic 
positive role of EHD proteins in sustaining antigen-driven T-cell responses in mature peripheral T 
cells, a role independent of any potential involvement of EHD proteins in events associated with 
thymic T-cell development. 
Coordination of multiple EAE-inducing T-cell functions, including their early activation, 
expansion, migration to the brain across the blood/brain barrier, and effector functions to mediate 
demyelination in the CNS are required for full disease induction (Furtado et al., 2008; O'Connor 
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et al., 2008). Therefore, we analyzed the impact of EHD1/3/4 deficiencies on the onset and 
progression of EAE. Since in vitro studies showed the T-cell proliferation and cytokine (IL-2) 
secretion to be impaired upon EHD1/3/4 deficiencies, we expected to see a delayed onset and 
reduced severity of EAE. While we saw no difference in the onset of disease, EHD1/3/4-null 
mice showed a decrease in the disease severity compared to control littermates.  Therefore, 
further in vitro and in vivo studies using models developed here should help to comprehensively 
reveal other aspects of T-cell function that also rely on EHD protein expression. 
Given the reduced TCR-CD3 levels in the CD4+ T-cells of our EHD1/3/4 -null mouse 
model prior to deliberate T-cell activation, our focus here has been on the role of EHD proteins in 
basal (prior to antigenic stimulation) TCR-CD3 traffic, which has not been mechanistically 
dissected in much detail. Therefore, further studies to identify partner proteins through which 
EHDs regulate TCR traffic will be of great interest. Notably, endocytic trafficking pathways play 
key roles during T-cell activation by orchestrating the polarized transport of TCR-CD3 and 
signaling molecules such as Lck to maintain an active immunologic synapse, and Rab4- and 
Rab11-positive endosomes are implicated in these processes (Soares et al., 2013).  
Cell biological studies have linked EHD proteins to the regulation of traffic in Rab11+ 
recycling endosomes as well as compartments regulated by other Rabs. Thus, further studies to 
examine the potential importance of EHD proteins in regulating endocytic traffic into and out of 
the IS during T-cell activation will be of great interest. In this regard, we and others have recently 
identified a key role of EHD proteins in primary cilia biogenesis (Bhattacharyya et al., 2016; Lu 
et al., 2015) and recent studies have shown that the maintenance of IS in cilia-less T-cells 
involves ciliogenesis-related proteins such as IFT20 which localize in the IS and are required for 
recycling of TCR-CD3 (Finetti et al., 2009; Finetti et al., 2014; Finetti et al., 2015). Although 
IFT20 KO under CD4-Cre led to only minor defects in T-cell development and collagen- induced 
arthritis (an experimental model of rheumatoid arthritis), earlier deletion using Lck-Cre led to 
64 
 
defective thymic development and T-cell function in vivo (Yuan, Garrett-Sinha, Sarkar, & Yang, 
2014); the latter are partially similar to the phenotype of our EHD1/3/4 KO mice. Interestingly, 
EHD1 and EHD3 were found to be important for the recruitment of transition zone proteins and 
IFT20 during ciliary vesicle formation (Lu et al., 2015). Though our study has been done mainly 
on freshly isolated and rested cells, it seems plausible that EHD proteins may also regulate the 
traffic of TCR-CD3 in the IS to promote T-cell activation and subsequent responses.  
Notably, the CD4-Cre mediated Wiskott-Aldrich syndrome protein and SCAR homolog 
(WASH) deletion led to T-cell defects strongly resembling the phenotype of EHD1/3/4 deficiency 
with minimal thymic developmental defects, reduced proliferation and cytokine production, a 
decrease in the surface TCR-CD3 levels, increase in lysosomal degradation of TCR-CD3, and 
reduced severity of EAE (Piotrowski, Gomez, Schoon, Mangalam, & Billadeau, 2013). WASH is 
an Arp2/3 activator that localizes on distinct endosomal subdomains and functions in endosomal 
trafficking (Jia et al., 2010). Given these phenotypic similarities of the two KO models and the 
interaction of the WASH protein with retromer complex and the involvement of EHD proteins in 
retromer-dependent transport (Gautreau, Oguievetskaia, & Ungermann, 2014; Seaman, 2012), 
further exploration of a link between EHD proteins and WASH complex in regulating TCR-CD3 
traffic will be of great interest.  
Overall, studies presented here using genetic models and functional analyses, in vivo and 
in vitro, reveal an important albeit redundant positive role of the newly described EHD family of 
endocytic recycling regulatory proteins in T-cell function. Mechanistically, we show that EHD 
proteins are required to facilitate basal recycling of TCR-CD3 from intracellular endocytic 
compartments back to the cell surface to ensure the surface expression of optimal TCR-CD3 
levels for subsequent antigen-driven T-cell activation. Future studies using the unique models 
described here should add to our understanding of the importance of endocytic traffic in the 
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control of TCR-CD3 and other receptors that regulate T-cell functions, as well as the roles of 
these proteins in other cells in the innate and adaptive arms of the immune system. 





Figure 1: Expression of EHDs in Lymphoid Tissues and Isolated CD4+ T-cells. A) Lymphoid tissues 
express all EHD proteins. One membrane (top) was probed with an antibody recognizing both EHD1 and 
EHD4, and a second one (bottom) probed for EHD3 followed by re-probing for EHD2. β-Actin was used as 
loading control. B) EHDs expression in T-cells. 40 µg of cell lysates from freshly isolated CD4+ T-cells 
(from the spleen of a WT mouse) and Jurkat cells were loaded on a 10% SDS PAGE gel; cell lysate from 
thymocytes was used as positive control. HSC70 was used as loading control.  Membranes were probed for 
EHD 1&4 (one antibody that detects both EHD 1and 4), and for EHD2. The EHD2 membrane was stripped 







































































Figure 2: EHD Proteins Show Differential Expression during T-cell Stimulation. A. CD4+ T-cells were 
freshly isolated from C57Bl/6 mice and were incubated with (+) or without (-) ant-mouse CD3Ɛ/CD28 for 
0, 24, and 48hrs for T-cell stimulation. Lysate of CD4+ T-cells from these time points and from the spleen 
and thymus of the same mice were run on 10% SDS PAGE gel. The membrane was probed for EHD1, 
EHD3, EHD4, and for β-Actin (loading control). B. Quantification of the western blots. Levels of EHD 









































































































































































Figure 3: Potential Redundant Functions of EHD Protein Family. A) EHD1 staining of the Lymph 
node and spleen from EHD1
-/- 





and Wt littermate mice were stimulated with anti-CD3Ɛ and anti CD28 for 72hrs and were 
subject to thymidine incorporation for the last 6 hrs of incubation. A representative figure of 3 independent 
experiments is shown. C) EHD1, EHD3 and EHD4 protein expression in lymphoid organs from Wt and 
EHD1-/- mice. Tissue lysate from these organs were loaded on a 10% SDS PAGE gel. D) Western blotting 
showing upregulation of EHD1 and EHD4 in the spleen and lymph nodes of EHD3-/- compared to tissues 
from Wt mice and upregulation of EHD4 in spleen and lymph nodes of EHD1
-/-
 compared to control 
tissues. Blots were probed for EHD1 and EHD4. E) Lymph nodes cells from Wt mice and EHD4-/- mice 
were stained with CFSE then stimulated with various concentration of anti-CD3 (1 µg/ml and 2.5 µg/ml) 
for 3 days. Cells were stained with anti-CD4 to look at the proliferation profile of CD4+ T-cells. FACS 
analysis of data modelled using ModFit software is shown. PI = proliferation index ± SEM of N = 3. F) 
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Figure 4: Generation of the TgTCR; CD4-Cre; EHD (1, 3, 4) flox/flox . Young mice (3-4 weeks old) were 
used for the FACs profile of the thymic development and older mice (6-8 weeks old) we used for rest of the 
















Figure 5: The CD4 Transgenic TCR Mice (2D2) Express Normal Levels of EHD Proteins and 
Respond to MOG Peptide, but not the OVA Control Peptide.  (A) Western blot of tissue lysates from 
the thymus and spleen of 2D2 mice (T = Tg TCR), Wt TCR littermate (W = non transgenic), and EHD1 
null mice (N = EHD1 null). N & W are used as control mice, M = marker.  EHD3 membrane was striped 
and re-probed for EHD2. 100 µg of tissue lysates were loaded in a 10% SDS PAGE gel. (B) Spleen cells 
from littermate with WT TCR, the WT C57BL/6J, and the Tg TCR mice were cultured with either the 
OVA peptide or the MOG peptide. Cells were pulsed with thymidine for the last 6 hrs of the 72 hrs 
incubation. Cells were harvested and radioactivity was counted. C) CFSE labeling was also used to check 
the specificity of the TgTCR. BMDC were pulsed with either the MOG peptide or OVA control peptide 
then were co-cultured together with CFSE labelled freshly purified CD4+T cells (92%) from the TgTCR for 
3 days. FACs analysis of day 0 and day 3 are shown.  D) Purity level of CD4+ T-cells used in this 
experiment. E) PCR of a mouse litter genotyped  with DNA extracted from tails showing an example of  4 
different offspring (#1, 2, 3, & 4)  with or without CD4-Cre; TgTCR,  and carrying EHD (1,3,4)
flox/flox
  for 
the conditional deletion of EHD1, 3, & 4 in T-cells.  F) FACS profile of cells from different lymphoid 
organs of TgTCR and control mice. Thymus showing % of CD4+ and CD8+ T-cells. Spleen showing % of 
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(Fig. 5F) Continued, 
 
































Figure 6: CD4-Cre Mediated Conditional Deletion of EHD 1, 3 and 4 does not Impact Thymic T-cell 
Development but Leads to a Relative Decrease in CD4+ T-cells in Secondary Lymphoid Tissues.  A) 
Western Blot verification of EHD1/3/4 deletions is shown. Lysates of freshly isolated splenocytes from the 
same mice before T-cell expansion were used as controls.  A representative blot of N = 6 is shown. B & C) 
There was no change in the absolute number of cells in the different lymphoid tissues of CD4-Cre+ mice.  
In B) cell numbers were counted in single cell preparations of the indicated lymphoid organs of 4-week-old 
CD4-Cre+ and CD4-Cre- (control) mice; N = 5. In C, the total spleen cell numbers from adult (6-8 weeks 
old) mice are shown; N = 5.   D & E) Analysis of thymic developmental stages in CD4-Cre+ and CD4-Cre- 
mice are shown. D) Top and middle panels show representative FACS plots with gating strategies used for 
analysis of cell subsets and developmental stages in thymocytes of 4-week-old mice. The numbers in 
quadrants represent the mean percentage of total thymocytes. Bottom shows quantification of middle panel. 
E) Top shows FACS plots with gating strategies and bottom shows quantification of relative percentages of 
cell subsets or cell numbers as in D), N = 4. F & G) Reduced percentages of T-cells in the spleen and 
increased percentages of B cells in the spleen and LN are shown.  Spleen (F) and LN cells (G) from 4-
week-old CD4-Cre+ and CD4-Cre- mice were analyzed by FACS for markers of B cells (B220+), CD8+ T-
cells and CD4+ T-cells (N=4).  Total cell numbers were calculated by multiplying the total live cell counts 
with the percentage of each subset. All values plotted as the mean ± SEM for indicated sample size. *, 
















































































































































































































































































































































































































Figure 7: Conditional Deletion of EHD 1, 3 and 4 in T-cells Leads to Reduced Cell Proliferation and 
IL-2 Secretion. A) A reduced proliferation by Cell-Trace Violet dye dilution assay is shown. Successive 
cell divisions were modeled with ModFit LT software and are shown as peaks of different colors. The 
figure is a representative of N = 3. The mean percentages of cells at successive divisions are shown on the 
right as a histogram. The proliferation index (PI) shown on top is the mean ± SEM of N = 3. *, p<0.05; **, 
p<0.01; ***, p<0.001; ****, p<0.0001; *****, p<0.00001.  B) Reduced proliferation seen by 3H-thymidine 
incorporation assay is shown. Shown is a representative figure of N = 2. C) Cells were stimulated as 
previously mentioned for the proliferation assays and stained with propidium iodide (PI) and anti-Annexin 
V antibody followed by FACS analysis for relative proportions of PI+/Annexin V+ apoptotic cells.  Values 
represent mean ± SEM. of N = 2 (NS, not significant). D) Spleen cells from EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; 
CreERT2; 2D2Tcr mice were stimulated with anti-CD3/CD28 in the presence or absence of 4-OH-tamoxifen 
(4-OHT) for four days to derive in vitro EHD 1/3/4-deleted T-cells vs. their WT controls.  Cells were 
washed, loaded with CFSE dye and re-stimulated with anti-CD3/CD28 for 72 hrs. Shown is a 
representative figure of N = 2. E) Western blot used to show depletion of EHD 1/3/4 in tamoxifen-treated 
T-cells. F) Quantification of the percentage of proliferating cells from the data shown in D).  G) Reduced 
IL-2 secretion is shown. Values represent mean ± SEM, N = 4, * p<0.05, **p<0.01).  H) There was a 
reduced severity of EAE in CD4-Cre+ mice. The plotted values are the composite mean scores ± SEM, N = 
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Figure 8: Conditional Deletion of EHD 1, 3 and 4 Leads to Impairment of Basal Recycling of TCR-
CD3 from Endocytic Compartments to the Cell Surface. A) The surface level of TCR-CD3, CD28 and 
LFA1 at steady state is shown. MFI values plotted are mean ± S. E. of N = 4 (*, p<0.05).  B) A relatively 
intact basal TCR-CD3 internalization is shown. N = 3; NS, not significant. C) Reduced recycling of pre-
existing endosomal TCR-CD3 is shown. The data represent mean ± SEM. of N = 4 (*p<0.05). D) The 
recycling of the labelled cell surface TCR-CD3 is shown. Cells were analyzed by FACS and MFI values 
used to quantify the proportion of internalized receptors that were still intracellular (acid wash-resistant 
fraction) and the percent of recycling was calculated as described in Methods. Values plotted are mean ± 


























































































































































































































































































































































Figure 9: Conditional Deletion of EHD 1, 3 and 4 Leads to a Reduced Level of the CD3Ɛ Component 
of TCR-CD3. A) Expanded T-cells from LN of CD4-Cre- or CD4-Cre+ mice probed for CD3Ɛ and either 
EHD1/4 or EHD3 proteins. B) Quantification of CD3Ɛ signals. Values plotted are mean ± SEM. of N = 5.  
C) LN cells from EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; CreERT2; 2D2-Tcr or EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; 2D2Tcr 
(control) mice were stimulated with anti-CD3/CD28 for four days in the presence (+) or absence (-) of 4-
OHT. Lysate from equal numbers of cells were loaded in each lane.  Western blot was carried out as in B. 
Shown is a representative blot run in duplicate. D) Quantification of CD3Ɛ signals for blot shown in C). E) 





































































































































































































Figure 10: Conditional Deletion of EHD 1, 3 and 4 Leads to Lysosomal Degradation of TCR-CD3.  A) 
T-cells expanded from LN of CD4-Cre- or CD4-Cre+ mice (7-8 days) were washed and treated with (+) or 
without (-) 100 nM Bafilomycin-A1 for 4 h at 37oC. Lysate from equal numbers of cells probed for CD3Ɛ 
and EHD1/4 and re-probed for EHD3, with β-actin as a loading control. A representative blot is shown. B) 
Quantification from data exhibited in A are shown here. Values plotted are mean ± SEM of N = 3. C) 
Expanded T-cells from LN of CD4-Cre- or CD4-Cre+ mice were treated with Bafilomycin-A1 as in A and 
stained with anti-CD3Ɛ (Red) and anti-LAMP1 (Green) antibodies followed by confocal imaging. Shown is 
a representative image of N=3. Scale bar = 2 µm.  D) Right, cells not treated with Bafilomycin-A, but 
stained as those in C).The red boxes indicate that the intracellular pools of CD3Ɛ were used to determine 
Pearson correlation coefficients from analyses of >50 cells per group as an indication of the extent of 
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10. Summary of all the Studies 
The endocytic trafficking pathways is a complex pathway used by all vertebrates. This 
pathway is extensively used in critical processes such as cell migration (Maritzen et al., 2015; 
Paul et al., 2015), receptor turn over (Irannejad et al., 2015), cell signaling (Barbieri et al., 2016; 
Irannejad et al., 2015; Platta & Stenmark, 2011; Villasenor et al., 2016), cell-to-cell 
communication (Onnis et al., 2016), and in other pathways such as pathogen invasion (Kulpa et 
al., 2013; Pirooz et al., 2014; Takeuchi et al., 2011), cell division (Chesneau et al., 2012; 
Schweitzer et al., 2011) , and membrane remodeling (Matsubayashi et al., 2015).  It is well 
documented that  mis-regulation of the endocytic trafficking is linked to different diseases 
including chronic hepatitis B virus (HBV) infections (Macovei et al., 2013; Watanabe et al., 
2007), cancer (Mellman & Yarden, 2013; Mosesson et al., 2008), HIV infection (Kulpa et al., 
2013), autoimmune diseases (Iglesias-Bartolome et al., 2009), etc.  Therefore, understanding how 
regulators of this complex pathway function is of great interest in basic and clinical immunology. 
On a cellular level, cells use this pathway for various reasons including the internalization 
of receptors and uptake of nutrients, ligands, other molecules and viruses. Cells use different 
routes to endocytose materials that include the clathrin-dependent pathway and the clathrin-
independent pathway. However, regardless of the pathway, the internalized receptors enter the 
early endosome (EE) where they are sorted for either traffic into late endosome/MVB and 
lysosome or for recycling back to the cell surface. This pathway is regulated by a few families of 
regulators such as Rab family of GTPases and more recently a growing number of researchers 
have demonstrated that the EHD protein family is among key regulators of this complex pathway. 
Our group and others have studied the role of EHD proteins both in vitro and in vivo. 
They regulate the transport of various receptors from different steps of the endocytic trafficking 
pathway. They have been shown to regulate the recycling of receptors from the EE to the RE, the 
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EE to the LE, and the retrograde transport through the Golgi. In non-immune cells systems, EHD 
proteins have been shown to regulate the transport of some key receptors such as MHC-I, TfR, 
and MHC-II that have been demonstrated in immune cells, to accumulate at the immunological 
synapse and be essential for the formation and maintenance of the IS (Caplan et al., 2002; Lin et 
al., 2001; Naslavsky & Caplan, 2011; Walseng et al., 2008). In addition, EHD proteins have been 
shown to regulate the neuronal synapse (Das et al., 2004; Ioannou & Marat, 2012; Ioannou & 
Marat, 2012; Jakobsson et al., 2011; Lasiecka et al., 2010; Valdez et al., 2005; Wei et al., 2010; 
Yap et al., 2010), the neuromuscular junction (Mate et al., 2012) , and the process of ciliogenesis 
(Bhattacharyya et al., 2016).  All of these process have been demonstrated to exhibit various 
similarities with the immunological synapse (Bezakova & Ruegg, 2003; Boulanger et al., 2001; 
Dustin & Colman, 2002; Finetti et al., 2009; Finetti et al., 2014; Griffiths et al., 2010; Tarakanov 
& Goncharova, 2009). However, though there is growing number of researchers interested in 
studying this family of proteins, their roles in immune cell functions were never investigated. 
Immune surveillance and rapid response by the immune system is essential to eliminate 
invading infectious agents and endogenous oncogenically-transformed cells. T-cells are major 
regulators and executioners of these functions. Effective generation of an immune response 
requires concurrent engagement of and signaling through co-stimulatory proteins (e.g., CD28) on 
T-cells by their cognate ligands on the APC surface (Huppa et al., 2003). Therefore, the 
mechanisms that ensure optimal levels of the TCR and accessory receptors on the T-cell surface 
prior to antigen stimulation are fundamentally critical to generating an effective immune 
response. However, mechanisms that regulate the surface pool of TCR and its accessory receptors 
have been primarily investigated in the context of T-cell activation.  
During T-cell activation, TCR signaling elicited by the APC-presented antigen, together 
with co-stimulatory signals, leads to spatial reorganization of the TCR and accessory receptors, 
such as CD28 and LFA-1, to form an area of intimate contact with APCs, the IS (Hashimoto-
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Tane et al., 2010; Jo et al., 2010). The endocytic pathways supply the IS with newly-synthesized 
and recycled receptors to replenish those that are targeted to the lysosome for degradation (Das et 
al., 2004; Lee et al., 2003; Valitutti et al., 1997) . T-cell receptors such as TCR-CD3 (Huppa et 
al., 2003), CD28 (Cefai et al., 1998) and LFA-1 (Fabbri et al., 2005; Stanley et al., 2012) are 
known to be internalized and recycled to the IS during T-cell activation. Internalized TCR-CD3 
traverses the Rab5+ EE, followed by transport through Rab4+ and Rab11+ endosomes, indicating 
the involvement of both fast and slow recycling pathways (Kumar et al., 2011; H. Liu et al., 
2000). Naïve and resting T-cells constitutively internalize and recycle their surface receptors and 
the balance of these processes dictates their pre-stimulation surface levels and hence the levels of 
T-cell activation (H. Liu et al., 2000). Yet, the mechanisms of constitutive basal traffic of TCR-
CD3 are not fully understood. 
Based on the importance of the endocytic traffic in T-cell function and IS formation and 
maintenance, we wanted to investigate the role of the EHD proteins in both T-cell function and in 
the IS. Given the importance of the endocytic trafficking in T-cell function and in IS during 
activation and the role the EHD proteins in the neuronal synapse, in neuromuscular junction, and 
in ciliogenesis, we  hypothesized that EHD protein will regulate the endocytic recycling of 
receptors in unstimulated and activated t cells respectively.   
Our group and others have shown that EHD proteins are expressed in spleen, so to 
expand on this, we checked the expression of EHD proteins in the spleen, thymus and in lymph 
nodes using western blotting and immunofluorescence staining. Our data confirmed previous data 
and also showed in other lymphoid organs that were not published before that all members of the 
EHD proteins family are expressed in all lymphoid organs tested (Fig. 1).  We then check their 
expression levels in primary T cells and cell lines. We show for the first time that multiple EHD 
proteins family members are expressed both in primary CD4+T-cells and in Jurkat cell line. This 
was shown both through western blotting and IF (Fig.1 and not shown).  
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To determine if EHD protein were important during T-cell activation, we stimulated 
freshly isolated CD4+T cells with or without anti-CD3/CD28 for 2 days and check the levels of 
EHD proteins at different time points. In our surprise, we saw that EHD1 and EHD4 levels went 
up over time with stimulation, while the level of EHD3 went down (Fig. 2). These results 
suggested that EHD proteins are important in T cell functions.  
We have used gene targeting in mice to reveal the in vivo functional roles of EHD 
proteins and cell surface receptors whose traffic is regulated by EHDs (Curran et al., 2014; 
Cypher et al., 2016; Demonbreun et al., 2015; Doherty et al., 2008; Gudmundsson et al., 2010; 
Posey et al., 2011; Posey et al., 2014) in other systems. We have previously generated single and 
combination knockout of EHD protein family. For example, EHD1 KO mice exhibit strain-
dependent phenotypes varying degrees of  embryonic lethality, male infertility, ocular 
developmental defects, and neural tube closure defects due to impairment of ciliogenesis and 
SHH signaling (Arya et al., 2015; Bhattacharyya et al., 2016). EHD3 null mice have cardiac 
abnormalities including arrhythmias and blunted response to adrenergic stimulation, and reduced 
expression of Na/Ca exchanger (NCX1) (Curran et al., 2014).  EHD4 null mice showed that EHD 
4 was required for normal pre-pubertal testis size in male and these males had reduced fertility. 
Whenever these mice were analyzed, they did not show any obvious immune defect phenotypes. 
A closer look at the CD4+T-cells from EHD1 and EHD4 null mice showed that deletion of EHD1 
protein individually did not cause a significant impact on T cell activation; however, deletion of 
EHD4 individually showed a decrease in T cell proliferation.  
Given the likelihood of redundant EHD function, we generated mice with a CD4-Cre-
depepndent, T-cell directed, conditional deletion of floxed Ehd1, Ehd3, and Ehd4 genes.  To 
examine the impact of EHD 1/3/4 deletions in T-cells in the context of antigen-specific responses, 
we also incorporated the MOG peptide-specific 2D2-Tcr transgene (Bettelli et al., 2003) into our 
conditional knockout model. Analysis of thymic T-cell development did not reveal any 
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significant alterations in total cellularity, T-cell subsets or relative proportions of T-cells at 
different stages in mice with a CD4-Cre mediated deletion of EHD1/3/4, indicating that EHD 
proteins are largely dispensable for thymic development beyond the CD4/8 double-positive stage. 
One limitation of this model is the fact that there is still one member present in these T-cells, so 
whether this might reflect any role of the remaining EHD family member, EHD2, remains a 
possibility that will require future studies. The second limitation of our model is that we are using 
CD4-cre in which deletion take place at the CD4/8 double positive.  It is still possible that EHD 
proteins are important at earlier stages of thymic development and future use of other Cre 
elements active at those stages will be needed to address this possibility. The third limitation of 
our models is the fact that our analyses were carried out in the context of a pre-rearranged TCR 
transgene; this could have masked a potential developmental role of EHD proteins in the context 
of a normally diverse TCR repertoire. More analysis of the thymic development is being 
conducted at this point to check if EHD proteins have any role during thymic development 
beyond the double positive stage of T-cell development.  
In contrast to the relatively unperturbed thymic development, CD4-Cre mediated 
EHD1/3/4 deletion led to a decrease in the percentage of T-cells in the periphery. This phenotype 
was seen in secondary lymphoid tissues, including the lymph nodes and the spleen. These results 
suggested that EHD proteins might play a more important role in mature peripheral T-cells. In 
addition, an apparent increase in the peripheral B cell numbers and their percentages was seen. 
The basis of this phenotype is unknown but is likely to reflect altered T-cell- B-cell interactions 
due to T-cell deficiency of EHD1/3/4. 
The in vitro analyses of T-cells from the CD4-Cre deletion model demonstrated 
significantly defective antigen-elicited CD4+ T-cell proliferation and IL-2 cytokine secretion 
responses upon EHD1/3/4 deletion.  Similar results were observed using CD4+ T-cells derived 
from an alternate model where in vitro deletion of floxed EHD1, 3 and 4 genes was induced with 
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4-OHT to bypass any in vivo developmental abnormalities. These results support a T-cell intrinsic 
positive role of EHD proteins in sustaining antigen-driven T-cell responses in mature peripheral 
T-cells, a role independent of any potential involvement of EHD proteins in events associated 
with thymic T-cell development. 
Research has shown that self-reactive T-cells from patients with multiple sclerosis and 
type1 diabetes form impaired IS. Their T-cells had TCRs signaling in the periphery with little or 
no accumulation of pMHC or TCR-pMHC complex transport to the cSMAC (Schubert et al., 
2012). Our antigen specific model, the 2D2 mouse model, is a well-established and accepted 
animal model of EAE which recapitulates many aspects of MS and has led to the development of 
different therapies approved for treatment of MS (Steinman & Zamvil, 2006). Understanding the 
trafficking mechanisms that ensure the polarized display of cell surface receptors in the IS will 
enhance our understanding of a key process in immune responses and could provide new 
approaches of immune intervention in highly prevalent diseases such as cancer and autoimmunity 
(Derniame, Vignaud, Faure, & Bene, 2008; Nicolaou et al., 2007). 
Coordination of multiple EAE-inducing T-cell functions, including their early activation, 
expansion, migration to the brain across the blood/brain barrier, and effector functions to mediate 
demyelination in the CNS are required for full disease induction (Furtado et al., 2008; O'Connor 
et al., 2008). It is important to note that about 4% of the 2D2 mice develop spontaneous EAE by 3 
to 5 months of age; however, all the mice used for these studies were 6-8 weeks old and the 
disease was induced by immunization with the MOG peptide. We analyzed the impact of 
EHD1/3/4 deficiencies on the onset and progression of EAE. Since in vitro studies showed the T-
cell proliferation and cytokine (IL-2) secretion to be impaired upon EHD1/3/4 deficiencies, we 
expected to see a delayed onset and reduced severity of EAE. While we saw no difference in the 
onset of disease, EHD1/3/4-null mice showed a decrease in the disease severity compared to 
control littermates.   
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Our studies on the importance of EHD proteins in IS formation and maintenance showed 
that EHD1 and EHD3 accumulate at the IS (T cell-APCs contact site) during T-cell activation 
(data not shown). Although our analysis never showed if the deletion of EHD proteins in T-cells 
could lead to impaired IS formation, the accumulation at the IS that we observed in our WT T-
cells still suggest that EHD could be required for the traffic of key receptors and integrin such as 
TCRs, CD28, CD25, and LFA-1in the IS. Again, these data suggest that EHD could have an 
important role in the IS as those CD4+ T-cells have to be activated first, then migrate to the brain 
to cause demyelination of the CNS. Therefore, these results demonstrate that EHD proteins play a 
functional role in T-cells in vivo.  Further in vitro and in vivo studies using models developed here 
should help to comprehensively reveal other aspects of T-cell function that also rely on EHD 
protein expression. 
Given the reduced TCR-CD3 levels in the CD4+T-cells of our EHD1/3/4 -null mouse 
model prior to deliberate T-cell activation, our focus was on the role of EHD proteins in basal 
(prior to antigenic stimulation) TCR-CD3 traffic, which has not been mechanistically dissected in 
much detail. Therefore, further studies to identify partner proteins through which EHDs regulate 
TCR traffic will be of great interest. Notably, endocytic trafficking pathways play key roles 
during T-cell activation by orchestrating the polarized transport of TCR-CD3 and signaling 
molecules such as Lck to maintain an active immunologic synapse, and Rab4- and Rab11-
positive endosomes are implicated in these processes (Soares et al., 2013).  
To assess whether EHD proteins regulate the traffic of TCR-CD3 or the accessory 
receptors, we first examined the cell surface levels of TCR-CD3, CD28, and LFA-1 by FACS 
analysis of unstimulated T-cells. T-cells from CD4-Cre+ mice expressed significantly lower levels 
of TCR-CD3 on the cell surface compared to T-cells from control mice (Fig 8A). When we 
analyzed in vitro activated CD4+ T-cells from CD4-Cre+ mice, we saw that they expressed lower 
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levels of TCR-CD3, CD28, CD25, CTLA-4 and LFA-1 compared to those from control mice. We 
also checked the levels of CD4 both in non-activated and activated and it did not change. 
Since EHD proteins are regulators of the endocytic trafficking pathway, we examined the 
kinetics of TCR-CD3 internalization and recycling in unstimulated CD4+ T-cells. Analysis of 
TCR-CD3 internalization using FACS showed that there was not significant difference in 
internalization of TCR in EHD1/3/4 -null T-cells compared to control T-cells (Fig. 8B). However, 
these T-cells exhibited a significantly reduced recycling of both the pre-existing intracellular pool 
of TCR-CD3 and the PE-labeled surface TCR-CD3 (back) to the cell surface at all-time points 
analyzed compared to control T-cells. Overall, these results show a key requirement of EHD 1, 3 
and 4 in basal recycling of TCR-CD3 from intracellular endocytic recycling compartments back 
to the cell surface. 
 We were also interested in checking the total level of TCR-CD3 in these EHD1/3/4-null 
T-cells (from CD4-Cre-mediated and 4OHT-induced ERT-Cre deletion).  Were examined the 
total levels of CD3Ɛ by western blotting and we found that deletion of EHD proteins led to a 
significant decrease in the total levels of CD3Ɛ (Fig. 9). Given our findings with the CSF-1 
receptor in macrophages (Cypher et al., 2016), we hypothesized that this reduction was likely due 
to lysosomal targeting and degradation. To test this hypothesis, we treated the EHD1/3/4-null T-
cells with or without bafilomycin-A1, an inhibitor of lysosomal degradation, for 4 h and analyzed 
the impact on total CD3Ɛ levels using western blotting and confocal. Western blot of cells treated 
with Bafilomycin A1 for 4 h showed a recovery of the CD3Ɛ protein level in EHD1/3/4 -null T-
cells, with levels in treated cells comparable to those in control cells.  Confocal imaging of 
control and EHD1/3/4 -null T-cells incubated with or without bafilomycin-A1 showed that 
relatively low CD3Ɛ staining was co-localized with the lysosomal marker LAMP-1 in untreated 
cells, but some co-localization was also seen in Bafilomycin A1-treated control T-cells. However, 
we saw significantly more lysosome-localized CD3Ɛ in EHD1/3/4-null cells treated with 
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bafilomycin-A1. These data suggested that EHD proteins promote the recycling of the TCR-CD3 
while preventing their lysosomal degradation. 
11. Conclusions 
Overall, studies presented here using genetic models and functional analyses in vivo and 
in vitro, reveal an important albeit redundant positive role of the newly-described EHD family of 
endocytic recycling regulatory proteins in T-cell function. Mechanistically, we show that EHD 
proteins are required to facilitate basal recycling of TCR-CD3 from intracellular endocytic 
compartments back to the cell surface to ensure the surface expression of optimal TCR-CD3 
levels for subsequent antigen-driven T-cell activation. Our founding support the conclusion that 
expression of EHD1/3/4 is required for efficient transport of TCR-CD3 from endosomal 
compartments back to the cell surface and to prevent its aberrant traffic into lysosomes.  
We also show that EHD1 and EHD3 accumulate at the IS (data not shown). These data 
suggest that EHD proteins could regulate the transport of important receptors and signaling 
molecule at the IS during T-cell activation. Altogether, our studies support the role of EHD 
proteins both before and during T-cell activation. Future studies using the unique models 
described here should add to our understanding of the importance of endocytic traffic in the 
control of TCR-CD3 and other receptors that regulate T-cell functions as well as the roles of these 
proteins in other cells in the innate and adaptive arms of the immune system. 
12. Future Directions 
Although our studies have reveal novel role of EHD proteins in T-cell function, there are 
still many questions that are left unanswered. Our model system used the deletion of EHD1, 
EHD3, and EHD4, while leaving EHD2 untouched. Although CD4+ T-cells express a low level of 
EHD2, it still does not rule out the possibility that EHD2 could have some role in T-cell function. 
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It will therefore be important to check that function of EHD2 either using the EHD2 null mice or 
using the inducible system established in our laboratory. Another question that is left unanswered 
is the actual role of each of the EHD proteins deleted in our system. Although initial studies were 
done using the EHD1null mice showed no significant difference compared to WT mice, initial 
studies using EHD4 null mice showed that their T-cells have a decreased proliferation compared 
to control T-cells.  It will be interesting to check if T-cells from EHD3 null mice will have no 
difference in proliferation compared to control T cells since EHD3 seems to be used differently 
than other EHDs during activation. 
 Our analysis of young mice showed that the percentage and absolute number of B cells 
increased in both the spleen and lymph nodes. The basis of this phenotype is not known. It will be 
great interest to investigate which sub-type of B cells caused this increase and to also check if 
their functions were affected. We also saw a slight change in the percentage of CD8+T-cells; 
however, since our model (2D2 mice) is known to be skewed toward the CD4+ T-cell 
compartment, it makes it difficult to know what role EHD proteins have in CD8+ T-cells. The use 
of a non-transgenic model to study thymic development and different T-cell sub-sets in the 
periphery is needed.  
We have analyzed some T-cell surface receptors such as CD28, LFA-1, CD25, and 
CTLA-4 and saw that deletion of EHD proteins led to their decrease from the cell surface. It will 
be interesting to study the role of EHD proteins in the traffic of CTLA-4, since they localize in 
endosomes in unstimulated T-cells and must be transported to the cell surface during T-cell 
activation.  
The mechanism by which EHD proteins regulate the traffic of TCR-CD3 is not known. 
Since either the TCR or the CD3Ɛ themselves do not contain NPF motifs, it suggest that there is 
another protein that links or associate them to endosomes positive for EHD proteins to regulate 
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their recycling back to the cell surface. It will be interesting to investigate which proteins link 
EHD proteins to TCR-CD3 for their transport. 
Our confocal analysis showed EHD protein expression in APCs (data not shown). Since 
we have an in vitro inducible system, we can study the role of EHD proteins in APCs. Also 
further studies to examine the potential importance of EHD proteins in regulating endocytic 
traffic into and out of the IS during T-cell activation will be of great interest. In this regard, our 
group and others have recently identified a key role of EHD proteins in primary cilia biogenesis 
(Bhattacharyya et al., 2016; Lu et al., 2015).  Recent studies have shown that the maintenance of 
IS in cilia-less T-cells involves ciliogenesis-related proteins such as IFT20 which localize in the 
IS and are required for recycling of TCR-CD3 (Finetti et al., 2009; Finetti et al., 2014; Finetti et 
al., 2015). Although IFT20 KO under CD4-Cre led to only minor defects in T-cell development 
and collagen- induced arthritis (an experimental model of rheumatoid arthritis), earlier deletion 
using Lck-Cre led to defective thymic development and T-cells function in vivo (Yuan et al., 
2014); the latter are partially similar to the phenotype of our EHD1/3/4 KO mice. Interestingly, 
the requirement of EHD1 and EHD3 were found to be important for the recruitment of transition 
zone proteins and IFT20 during ciliary vesicle formation (Lu et al., 2015). Though our study has 
been done mainly on freshly isolated and rested cells, it seems plausible that EHD proteins may 
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